c-Myb	B-DNA
and	O
Ets	B-protein
proteins	I-protein
synergize	O
to	O
overcome	O
transcriptional	O
repression	O
by	O
ZEB	B-protein
.	O

The	O
Zfh	B-protein
family	I-protein
of	O
zinc	B-protein
finger/homeodomain	I-protein
proteins	I-protein
was	O
first	O
identified	O
in	O
Drosophila	O
where	O
it	O
is	O
required	O
for	O
differentiation	O
of	O
tissues	O
such	O
as	O
the	O
central	O
nervous	O
system	O
and	O
muscle	O
.	O

ZEB	B-protein
,	O
a	O
vertebrate	O
homolog	O
of	O
Zfh-1	B-protein
,	O
binds	O
a	O
subset	O
of	O
E	B-DNA
boxes	I-DNA
and	O
blocks	O
myogenesis	O
through	O
transcriptional	O
repression	O
of	O
muscle	B-DNA
genes	I-DNA
.	O

We	O
present	O
evidence	O
here	O
that	O
ZEB	B-protein
also	O
has	O
an	O
important	O
role	O
in	O
controlling	O
hematopoietic	B-DNA
gene	I-DNA
transcription	O
.	O

Two	O
families	O
of	O
transcription	B-protein
factors	I-protein
that	O
are	O
required	O
for	O
normal	O
hematopoiesis	O
are	O
c-Myb	B-protein
and	O
Ets	B-protein
.	O

These	O
factors	O
act	O
synergistically	O
to	O
activate	O
transcription	O
,	O
and	O
this	O
synergy	O
is	O
required	O
for	O
transcription	O
of	O
at	O
least	O
several	O
important	O
hematopoietic	B-DNA
genes	I-DNA
.	O

ZEB	B-protein
blocks	O
the	O
activity	O
of	O
c-Myb	B-protein
and	O
Ets	B-protein
individually	O
,	O
but	O
together	O
the	O
factors	O
synergize	O
to	O
resist	O
this	O
repression	O
.	O

Such	O
repression	O
imposes	O
a	O
requirement	O
for	O
both	O
c-Myb	B-protein
and	O
Ets	B-protein
for	O
transcriptional	O
activity	O
,	O
providing	O
one	O
explanation	O
for	O
why	O
synergy	O
between	O
these	O
factors	O
is	O
important	O
.	O

The	O
balance	O
between	O
repression	O
by	O
ZEB	B-protein
and	O
transcriptional	O
activation	O
by	O
c-Myb	B-protein
/Ets	B-protein
provides	O
a	O
flexible	O
regulatory	O
mechanism	O
for	O
controlling	O
gene	O
expression	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

We	O
demonstrate	O
that	O
one	O
target	O
of	O
this	O
positive/negative	O
regulation	O
in	O
vivo	O
is	O
the	O
alpha4	B-protein
integrin	I-protein
,	O
which	O
play	O
a	O
key	O
role	O
in	O
normal	O
hematopoiesis	O
and	O
function	O
of	O
mature	B-cell_type
leukocytes	I-cell_type
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.16	NULL
No.13	NULL
pp.3924-3934	NULL
,	NULL
1997	NULL
c-Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
synergize	NULL
to	NULL
overcome	NULL
transcriptional	NULL
repression	NULL
by	NULL
ZEB	NULL
Antonio	NULL
A.Postigo	NULL
,	NULL
Allan	NULL
M.Sheppard	NULL
,	NULL
Michael	NULL
L.Mucenski	NULL
'	NULL
and	NULL
Douglas	NULL
C.Dean*	NULL
Departments	NULL
of	NULL
Medicine	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
Washington	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
63110	NULL
and	NULL
'Division	NULL
of	NULL
Biology	NULL
,	NULL
Oak	NULL
Ridge	NULL
National	NULL
Laboratory	NULL
,	NULL
Oak	NULL
Ridge	NULL
,	NULL
TN	NULL
37831	NULL
,	NULL
USA	NULL
Corresponding	NULL
author	NULL
e-mail	NULL
:	NULL
dean	NULL
@	NULL
im.wustl.edu	NULL
The	NULL
Zfh	NULL
family	NULL
of	NULL
zinc	NULL
finger/homeodomain	NULL
proteins	NULL
was	NULL
first	NULL
identified	NULL
in	NULL
Drosophila	NULL
where	NULL
it	NULL
is	NULL
required	NULL
for	NULL
differentiation	NULL
of	NULL
tissues	NULL
such	NULL
as	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
and	NULL
muscle	NULL
.	NULL

ZEB	NULL
,	NULL
a	NULL
vertebrate	NULL
homolog	NULL
of	NULL
Zfh-1	NULL
,	NULL
binds	NULL
a	NULL
subset	NULL
of	NULL
E	NULL
boxes	NULL
and	NULL
blocks	NULL
myogenesis	NULL
through	NULL
transcriptional	NULL
repression	NULL
of	NULL
muscle	NULL
genes	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
here	NULL
that	NULL
ZEB	NULL
also	NULL
has	NULL
an	NULL
important	NULL
role	NULL
in	NULL
controlling	NULL
hematopoietic	NULL
gene	NULL
transcription	NULL
.	NULL

Two	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
required	NULL
for	NULL
normal	NULL
hematopoiesis	NULL
are	NULL
c-Myb	NULL
and	NULL
Ets	NULL
.	NULL

These	NULL
factors	NULL
act	NULL
synergistically	NULL
to	NULL
activate	NULL
transcription	NULL
,	NULL
and	NULL
this	NULL
synergy	NULL
is	NULL
required	NULL
for	NULL
transcription	NULL
of	NULL
at	NULL
least	NULL
several	NULL
important	NULL
hematopoietic	NULL
genes	NULL
.	NULL

ZEB	NULL
blocks	NULL
the	NULL
activity	NULL
of	NULL
c-Myb	NULL
and	NULL
Ets	NULL
individually	NULL
,	NULL
but	NULL
together	NULL
the	NULL
factors	NULL
synergize	NULL
to	NULL
resist	NULL
this	NULL
repression	NULL
.	NULL

Such	NULL
repression	NULL
imposes	NULL
a	NULL
requirement	NULL
for	NULL
both	NULL
c-Myb	NULL
and	NULL
Ets	NULL
for	NULL
transcriptional	NULL
activity	NULL
,	NULL
providing	NULL
one	NULL
explanation	NULL
for	NULL
why	NULL
synergy	NULL
between	NULL
these	NULL
factors	NULL
is	NULL
important	NULL
.	NULL

The	NULL
balance	NULL
between	NULL
repression	NULL
by	NULL
ZEB	NULL
and	NULL
transcriptional	NULL
activation	NULL
by	NULL
c-Myb/Ets	NULL
provides	NULL
a	NULL
flexible	NULL
regulatory	NULL
mechanism	NULL
for	NULL
controlling	NULL
gene	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
one	NULL
target	NULL
of	NULL
this	NULL
positive/negative	NULL
regulation	NULL
in	NULL
vivo	NULL
is	NULL
the	NULL
4	NULL
integrin	NULL
,	NULL
which	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
normal	NULL
hematopoiesis	NULL
and	NULL
function	NULL
of	NULL
mature	NULL
leukocytes	NULL
.	NULL

Keywords	NULL
:	NULL
c-Myb/Ets/hematopoiesis/o4	NULL
integrin/	NULL
repression/ZEB	NULL
Introduction	NULL
The	NULL
Zfh	NULL
family	NULL
is	NULL
comprised	NULL
of	NULL
zinc	NULL
finger/homeodomain	NULL
proteins	NULL
that	NULL
were	NULL
first	NULL
identified	NULL
in	NULL
Drosophila	NULL
where	NULL
they	NULL
are	NULL
required	NULL
for	NULL
proper	NULL
differentiation	NULL
of	NULL
tissues	NULL
such	NULL
as	NULL
the	NULL
central	NULL
nervous	NULL
system	NULL
(	NULL
CNS	NULL
)	NULL
and	NULL
muscle	NULL
(	NULL
Fortini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Lai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
the	NULL
Zfh	NULL
protein	NULL
in	NULL
Drosophila	NULL
is	NULL
unknown	NULL
.	NULL

A	NULL
vertebrate	NULL
homolog	NULL
of	NULL
Drosophila	NULL
Zfh-2	NULL
,	NULL
ATBF-1	NULL
,	NULL
has	NULL
been	NULL
identified	NULL
and	NULL
shown	NULL
to	NULL
repress	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
a-fetoprotein	NULL
gene	NULL
(	NULL
Yasuda	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
recently	NULL
that	NULL
the	NULL
vertebrate	NULL
homolog	NULL
of	NULL
Drosophila	NULL
Zfh-1	NULL
,	NULL
ZEB	NULL
,	NULL
represses	NULL
muscle	NULL
genes	NULL
and	NULL
regulates	NULL
myogenic	NULL
differentiation	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
Zth	NULL
family	NULL
appears	NULL
to	NULL
regulate	NULL
tissue	NULL
differentiation	NULL
by	NULL
repressing	NULL
gene	NULL
transcription	NULL
.	NULL

ZEB	NULL
binds	NULL
to	NULL
a	NULL
subset	NULL
of	NULL
E	NULL
boxes	NULL
(	NULL
CANNTG	NULL
)	NULL
with	NULL
the	NULL
3924	NULL
sequence	NULL
CACCTG	NULL
(	NULL
Genetta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Once	NULL
bound	NULL
to	NULL
these	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
region	NULL
of	NULL
muscle	NULL
genes	NULL
,	NULL
ZEB	NULL
represses	NULL
transcription	NULL
and	NULL
blocks	NULL
muscle	NULL
differentiation	NULL
.	NULL

ZEB	NULL
is	NULL
displaced	NULL
from	NULL
these	NULL
E	NULL
boxes	NULL
as	NULL
myogenic	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
(	NULL
bHLH	NULL
)	NULL
(	NULL
myoD	NULL
,	NULL
myogenin	NULL
,	NULL
myf-5	NULL
,	NULL
MRF-4	NULL
)	NULL
,	NULL
that	NULL
also	NULL
bind	NULL
to	NULL
these	NULL
sites	NULL
,	NULL
accumulate	NULL
during	NULL
muscle	NULL
differentiation	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
interplay	NULL
between	NULL
ZEB	NULL
and	NULL
bHLH	NULL
proteins	NULL
at	NULL
different	NULL
genes	NULL
may	NULL
provide	NULL
a	NULL
mechanism	NULL
for	NULL
imposing	NULL
temporal	NULL
order	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
muscle	NULL
genes	NULL
.	NULL

Zfh-1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
CNS	NULL
,	NULL
and	NULL
its	NULL
overexpression	NULL
results	NULL
in	NULL
an	NULL
early	NULL
embryonic	NULL
lethal	NULL
phenotype	NULL
with	NULL
severe	NULL
CNS	NULL
defects	NULL
in	NULL
Drosophila	NULL
(	NULL
Fortini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

ZEB	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
the	NULL
CNS	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
may	NULL
have	NULL
a	NULL
role	NULL
in	NULL
differentiation	NULL
of	NULL
other	NULL
tissues	NULL
in	NULL
addition	NULL
to	NULL
muscle	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
ZEB	NULL
was	NULL
described	NULL
originally	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
although	NULL
no	NULL
transcriptional	NULL
activity	NULL
was	NULL
reported	NULL
(	NULL
Genetta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
investigated	NULL
a	NULL
role	NULL
for	NULL
ZEB	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

One	NULL
target	NULL
of	NULL
ZEB	NULL
in	NULL
myogenesis	NULL
is	NULL
the	NULL
4	NULL
integrin	NULL
gene	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

o4	NULL
is	NULL
one	NULL
of	NULL
a	NULL
number	NULL
of	NULL
integrins	NULL
that	NULL
associate	NULL
with	NULL
a	NULL
common	NULL
B1	NULL
subunit	NULL
(	NULL
Lobb	NULL
and	NULL
Hemler	NULL
,	NULL
1994	NULL
;	NULL
Springer	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

o4	NULL
integrin	NULL
is	NULL
expressed	NULL
early	NULL
in	NULL
muscle	NULL
development	NULL
where	NULL
it	NULL
interacts	NULL
with	NULL
its	NULL
ligand	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
(	NULL
VCAM-1	NULL
)	NULL
to	NULL
mediate	NULL
cell-cell	NULL
interactions	NULL
important	NULL
for	NULL
myogenesis	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Sheppard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Interestigly	NULL
,	NULL
G4	NULL
integrin	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
where	NULL
it	NULL
has	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
of	NULL
all	NULL
hematopoietic	NULL
lineages	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
fibronectin	NULL
and	NULL
VCAM-1	NULL
in	NULL
the	NULL
stromal	NULL
matrix	NULL
and	NULL
stromal	NULL
cells	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
and	NULL
fetal	NULL
liver	NULL
(	NULL
Miyake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Roldan	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Teixido	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

o4	NULL
is	NULL
expressed	NULL
before	NULL
most	NULL
lineage-specific	NULL
markers	NULL
on	NULL
all	NULL
hematopoietic	NULL
cell	NULL
lineages	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
hematopoiesis	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Hamamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
hematopoietic	NULL
differentiation	NULL
proceeds	NULL
,	NULL
its	NULL
expression	NULL
becomes	NULL
restricted	NULL
to	NULL
only	NULL
a	NULL
few	NULL
lineages	NULL
such	NULL
as	NULL
lymphocytes	NULL
and	NULL
some	NULL
subsets	NULL
of	NULL
myeloid	NULL
cells	NULL
,	NULL
where	NULL
it	NULL
continues	NULL
to	NULL
function	NULL
by	NULL
targeting	NULL
these	NULL
leukocytes	NULL
to	NULL
sites	NULL
of	NULL
inflammation	NULL
(	NULL
Lobb	NULL
and	NULL
Hemler	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
,	NULL
together	NULL
with	NULL
recent	NULL
reports	NULL
showing	NULL
that	NULL
4	NULL
is	NULL
required	NULL
in	NULL
vivo	NULL
for	NULL
normal	NULL
hematopoiesis	NULL
in	NULL
mice	NULL
(	NULL
Hamamura	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Arroyo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
indicate	NULL
an	NULL
important	NULL
role	NULL
for	NULL
4	NULL
in	NULL
hematopoiesis	NULL
and	NULL
leukocyte	NULL
function	NULL
.	NULL

(	NULL
4	NULL
integrin	NULL
expression	NULL
continues	NULL
to	NULL
be	NULL
regulated	NULL
in	NULL
mature	NULL
leukocytes	NULL
as	NULL
G4	NULL
expression	NULL
is	NULL
up-regulated	NULL
during	NULL
mitogenic	NULL
activation	NULL
(	NULL
Sanchez-Madrid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
and	NULL
differentially	NULL
regulated	NULL
among	NULL
lymphoid	NULL
subsets	NULL
(	NULL
Shimizu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Picker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
demonstrate	NULL
that	NULL
ZEB	NULL
activity	NULL
,	NULL
and	NULL
hence	NULL
(	NULL
4	NULL
integrin	NULL
expression	NULL
,	NULL
is	NULL
regulated	NULL
in	NULL
hematopoietic	NULL
cells	NULL
through	NULL
a	NULL
mechanism	NULL
distinct	NULL
from	NULL
that	NULL
which	NULL
we	NULL
have	NULL
characterized	NULL
in	NULL
muscle	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Instead	NULL
of	NULL
being	NULL
displaced	NULL
from	NULL
the	NULL
promoter	NULL
by	NULL
bHLH	NULL
proteins	NULL
,	NULL
the	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
c-Myb	NULL
synergizes	NULL
with	NULL
Ets	NULL
proteins	NULL
to	NULL
resist	NULL
repression	NULL
by	NULL
ZEB	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
regulating	NULL
the	NULL
04	NULL
gene	NULL
,	NULL
c-Myb	NULL
and	NULL
Ets	NULL
also	NULL
play	NULL
a	NULL
crucial	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
other	NULL
hematopoietic	NULL
genes	NULL
and	NULL
thus	NULL
in	NULL
hematopoiesis	NULL
itself	NULL
(	NULL
Graf	NULL
,	NULL
1992	NULL
;	NULL
Lipsick	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
ets	NULL
and	NULL
c-myb	NULL
genes	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
severely	NULL
affect	NULL
the	NULL
proper	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Muthusamy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Shivdasani	NULL
and	NULL
Orkin	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
E26	NULL
virus	NULL
,	NULL
which	NULL
carries	NULL
the	NULL
v-myb	NULL
oncogene	NULL
as	NULL
a	NULL
fusion	NULL
with	NULL
v-ets	NULL
,	NULL
efficiently	NULL
induces	NULL
erythroleukemia	NULL
,	NULL
whereas	NULL
avian	NULL
myelo-blastosis	NULL
virus	NULL
(	NULL
AMV	NULL
;	NULL
which	NULL
carries	NULL
v-myb	NULL
but	NULL
lacks	NULL
v-ets	NULL
)	NULL
does	NULL
not	NULL
(	NULL
Radke	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1982	NULL
;	NULL
Metz	NULL
and	NULL
Graf	NULL
,	NULL
1991	NULL
@	NULL
,	NULL
b	NULL
)	NULL
,	NULL
providing	NULL
evidence	NULL
of	NULL
the	NULL
potent	NULL
effect	NULL
of	NULL
the	NULL
synergism	NULL
between	NULL
c-Myb	NULL
and	NULL
Ets	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
hematopoietic	NULL
genes	NULL
and	NULL
specific	NULL
steps	NULL
in	NULL
hematopoiesis	NULL
.	NULL

Only	NULL
a	NULL
few	NULL
hematopoietic	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
as	NULL
targets	NULL
of	NULL
c-Myb	NULL
,	NULL
and	NULL
it	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
several	NULL
of	NULL
these	NULL
genes	NULL
which	NULL
have	NULL
been	NULL
examined	NULL
in	NULL
detail	NULL
are	NULL
dependent	NULL
upon	NULL
synergism	NULL
between	NULL
c-Myb	NULL
and	NULL
Ets	NULL
.	NULL

Such	NULL
genes	NULL
include	NULL
the	NULL
early	NULL
myeloid	NULL
markers	NULL
mim-1	NULL
(	NULL
Ness	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
;	NULL
Dudek	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
CD13	NULL
(	NULL
Shapiro	NULL
,	NULL
1995	NULL
)	NULL
,	NULL
CD4	NULL
(	NULL
Siu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
,	NULL
p56	NULL
``	NULL
(	NULL
McCracken	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
the	NULL
early	NULL
hematopoietic	NULL
marker	NULL
CD34	NULL
(	NULL
Melotti	NULL
and	NULL
Calabretta	NULL
,	NULL
1994	NULL
;	NULL
Melotti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
with	NULL
some	NULL
of	NULL
these	NULL
genes	NULL
that	NULL
expression	NULL
is	NULL
not	NULL
induced	NULL
by	NULL
c-Myb	NULL
or	NULL
Ets	NULL
separately	NULL
,	NULL
but	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
factors	NULL
(	NULL
McCracken	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
,	NULL
as	NULL
with	NULL
the	NULL
oA	NULL
gene	NULL
,	NULL
this	NULL
synergy	NULL
may	NULL
overcome	NULL
a	NULL
silencer	NULL
that	NULL
blocks	NULL
activity	NULL
of	NULL
the	NULL
factors	NULL
individually	NULL
.	NULL

Indeed	NULL
,	NULL
such	NULL
silencer	NULL
elements	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
some	NULL
of	NULL
the	NULL
above	NULL
genes	NULL
(	NULL
Allen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Sawada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Perrotti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Duncan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
repressor	NULL
protein	NULL
has	NULL
not	NULL
been	NULL
characterized	NULL
for	NULL
CD4	NULL
and	NULL
p56	NULL
'	NULL
``	NULL
*	NULL
,	NULL
ZEB	NULL
sites	NULL
are	NULL
evident	NULL
in	NULL
both	NULL
genes	NULL
,	NULL
suggesting	NULL
that	NULL
ZEB	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
silencer	NULL
activity	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
ZEB	NULL
is	NULL
important	NULL
in	NULL
regulating	NULL
gene	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Regulation	NULL
of	NULL
ZEB	NULL
activity	NULL
in	NULL
hematopoietic	NULL
cells	NULL
is	NULL
distinct	NULL
from	NULL
that	NULL
in	NULL
muscle	NULL
,	NULL
and	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
a	NULL
fine	NULL
balance	NULL
between	NULL
repression	NULL
by	NULL
ZEB	NULL
and	NULL
synergistic	NULL
activation	NULL
by	NULL
c-Myb	NULL
and	NULL
Ets	NULL
regulates	NULL
gene	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Results	NULL
ZEB	NULL
is	NULL
expressed	NULL
and	NULL
binds	NULL
ZEB	NULL
sites	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
but	NULL
it	NULL
does	NULL
not	NULL
repress	NULL
gene	NULL
expression	NULL
ZEB	NULL
blocks	NULL
muscle	NULL
differentiation	NULL
by	NULL
repressing	NULL
muscle	NULL
genes	NULL
.	NULL

One	NULL
such	NULL
gene	NULL
is	NULL
4	NULL
integrin	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
its	NULL
expression	NULL
in	NULL
muscle	NULL
,	NULL
(	NULL
4	NULL
integrin	NULL
has	NULL
a	NULL
key	NULL
role	NULL
in	NULL
hematopoietic	NULL
differentiation	NULL
,	NULL
leukocyte	NULL
trafficking	NULL
and	NULL
recruitment	NULL
of	NULL
leukocytes	NULL
to	NULL
sites	NULL
of	NULL
inflammation	NULL
(	NULL
Miyake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Yednock	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Lobb	NULL
and	NULL
Hemler	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
04	NULL
integrin	NULL
on	NULL
hematopoietic	NULL
cells	NULL
and	NULL
VCAM-1	NULL
and	NULL
fibronectin	NULL
on	NULL
stromal	NULL
cells	NULL
and	NULL
stromal	NULL
matrix	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
and	NULL
bone	NULL
marrow	NULL
is	NULL
important	NULL
for	NULL
normal	NULL
hematopoiesis	NULL
(	NULL
Miyake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Roldan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Previous	NULL
results	NULL
demonstrated	NULL
that	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
first	NULL
c-Myb/Ets	NULL
overcome	NULL
ZEB	NULL
repression	NULL
76	NULL
bp	NULL
of	NULL
the	NULL
(	NULL
4	NULL
promoter	NULL
gene	NULL
are	NULL
active	NULL
in	NULL
most	NULL
cell	NULL
types	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
,	NULL
making	NULL
it	NULL
unlikely	NULL
that	NULL
these	NULL
sites	NULL
alone	NULL
could	NULL
account	NULL
for	NULL
the	NULL
restricted	NULL
pattern	NULL
of	NULL
o4	NULL
expression	NULL
.	NULL

In	NULL
order	NULL
to	NULL
understand	NULL
how	NULL
the	NULL
0A	NULL
gene	NULL
is	NULL
regulated	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
we	NULL
transfected	NULL
04	NULL
gene	NULL
promoter	NULL
constructs	NULL
into	NULL
G4	NULL
(	NULL
+	NULL
)	NULL
and	NULL
(	NULL
4	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
.	NULL

In	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
was	NULL
blocked	NULL
in	NULL
constructs	NULL
containing	NULL
sequences	NULL
upstream	NULL
of	NULL
-300	NULL
bp	NULL
(	NULL
Figure	NULL
1A-D	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
of	NULL
promoter	NULL
activity	NULL
was	NULL
the	NULL
same	NULL
as	NULL
the	NULL
pattern	NULL
we	NULL
found	NULL
in	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
myoblasts	NULL
(	NULL
Figure	NULL
1D	NULL
,	NULL
and	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Two	NULL
ZEB	NULL
sites	NULL
(	NULL
at	NULL
positions	NULL
-361	NULL
and	NULL
-399	NULL
bp	NULL
)	NULL
are	NULL
responsible	NULL
for	NULL
this	NULL
silencer	NULL
activity	NULL
in	NULL
myoblasts	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

When	NULL
the	NULL
same	NULL
constructs	NULL
were	NULL
transfected	NULL
into	NULL
the	NULL
o4	NULL
(	NULL
+	NULL
)	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
,	NULL
the	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
HEL	NULL
or	NULL
the	NULL
B	NULL
cell	NULL
line	NULL
Raji	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
activity	NULL
is	NULL
maintained	NULL
in	NULL
promoter	NULL
constructs	NULL
extending	NULL
to	NULL
-2.0	NULL
kb	NULL
(	NULL
Figure	NULL
1E	NULL
and	NULL
F	NULL
)	NULL
as	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
myoblasts	NULL
differentiate	NULL
into	NULL
x4	NULL
(	NULL
+	NULL
)	NULL
myotubes	NULL
(	NULL
Figure	NULL
1H	NULL
)	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
repressor	NULL
activity	NULL
suggested	NULL
that	NULL
ZEB	NULL
may	NULL
not	NULL
be	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
we	NULL
found	NULL
that	NULL
Jurkat	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
ZEB	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
,	NULL
and	NULL
ZEB	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Genetta	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

In	NULL
muscle	NULL
,	NULL
ZEB	NULL
is	NULL
displaced	NULL
from	NULL
E361	NULL
and	NULL
E399	NULL
by	NULL
bHLH	NULL
proteins	NULL
as	NULL
(	NULL
4	NULL
(	NULL
-	NULL
)	NULL
myoblasts	NULL
differentiate	NULL
into	NULL
O4	NULL
(	NULL
+	NULL
)	NULL
myotubes	NULL
(	NULL
Figure	NULL
1D	NULL
and	NULL
H	NULL
,	NULL
and	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Even	NULL
though	NULL
ZEB	NULL
is	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
that	NULL
the	NULL
ratio	NULL
of	NULL
ZEB	NULL
to	NULL
bHLH	NULL
proteins	NULL
(	NULL
E	NULL
proteins	NULL
)	NULL
is	NULL
low	NULL
and	NULL
ZEB	NULL
is	NULL
prevented	NULL
from	NULL
binding	NULL
ZEB	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
increasing	NULL
this	NULL
ratio	NULL
by	NULL
overexpression	NULL
of	NULL
ZEB	NULL
in	NULL
hematopoietic	NULL
cells	NULL
did	NULL
not	NULL
result	NULL
in	NULL
repressor	NULL
activity	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
,	NULL
contrary	NULL
to	NULL
myotubes	NULL
where	NULL
overexpression	NULL
of	NULL
ZEB	NULL
displaced	NULL
myoD/E	NULL
proteins	NULL
complexes	NULL
from	NULL
E	NULL
boxes	NULL
and	NULL
blocked	NULL
o4	NULL
promoter	NULL
activity	NULL
(	NULL
Figure	NULL
2C	NULL
,	NULL
and	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
capacity	NULL
of	NULL
ZEB	NULL
to	NULL
bind	NULL
ZEB	NULL
sites	NULL
from	NULL
the	NULL
oA	NULL
promoter	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
with	NULL
E361	NULL
and	NULL
E399	NULL
gave	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
nuclear	NULL
protein	NULL
binding	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
04	NULL
(	NULL
+	NULL
)	NULL
hematopoietic	NULL
cells	NULL
and	NULL
with	NULL
(	NULL
4	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
;	NULL
we	NULL
found	NULL
binding	NULL
of	NULL
ZEB	NULL
along	NULL
with	NULL
the	NULL
ubiquitous	NULL
bHLH	NULL
protein	NULL
USF	NULL
(	NULL
upstream	NULL
stimulatory	NULL
factor	NULL
)	NULL
(	NULL
Sawadogo	NULL
and	NULL
Roeder	NULL
,	NULL
1985	NULL
)	NULL
(	NULL
Figure	NULL
3A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
ZEB	NULL
sites	NULL
bind	NULL
only	NULL
weakly	NULL
to	NULL
USF	NULL
,	NULL
and	NULL
overexpression	NULL
of	NULL
USF	NULL
did	NULL
not	NULL
activate	NULL
or	NULL
repress	NULL
transcription	NULL
through	NULL
the	NULL
ZEB	NULL
sites	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
repression	NULL
of	NULL
the	NULL
o4	NULL
promoter	NULL
observed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
was	NULL
not	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
binding	NULL
of	NULL
ZEB	NULL
to	NULL
its	NULL
sites	NULL
in	NULL
the	NULL
oA	NULL
promoter	NULL
.	NULL

ZEB	NULL
sites	NULL
are	NULL
silencers	NULL
in	NULL
hematopoietic	NULL
cells	NULL
One	NULL
explanation	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
ZEB	NULL
repressor	NULL
activity	NULL
in	NULL
hematopoietic	NULL
cells	NULL
was	NULL
that	NULL
a	NULL
hematopoietic-specific	NULL
transcription	NULL
factor	NULL
may	NULL
block	NULL
ZEB	NULL
function	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
o4	NULL
gene	NULL
promoter	NULL
.	NULL

To	NULL
investigate	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
first	NULL
examined	NULL
the	NULL
activity	NULL
of	NULL
ZEB	NULL
sites	NULL
out	NULL
of	NULL
the	NULL
context	NULL
of	NULL
the	NULL
o4	NULL
promoter	NULL
.	NULL

ZEB	NULL
sites	NULL
efficiently	NULL
blocked	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
from	NULL
the	NULL
o4	NULL
promoter	NULL
in	NULL
04	NULL
(	NULL
+	NULL
)	NULL
hematopoietic	NULL
cells	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
G4	NULL
(	NULL
-	NULL
)	NULL
cell	NULL
types	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
04	NULL
(	NULL
+	NULL
)	NULL
myotubes	NULL
where	NULL
the	NULL
loss	NULL
of	NULL
ZEB	NULL
activity	NULL
(	NULL
E361	NULL
and	NULL
E399	NULL
did	NULL
not	NULL
have	NULL
any	NULL
repressor	NULL
effect	NULL
on	NULL
Ets	NULL
activity	NULL
)	NULL
was	NULL
the	NULL
result	NULL
of	NULL
the	NULL
displacement	NULL
of	NULL
ZEB	NULL
by	NULL
myoD/E12	NULL
3925	NULL
A.A.Postigo	NULL
et	NULL
al	NULL
.	NULL

J	NULL
»	NULL
&	NULL
``	NULL
°	NULL
HT-1080	NULL
,	NULL
fibrosarcoma	NULL
,	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
3	NULL
P	NULL
<	NULL
E	NULL
a	NULL
50	NULL
B	NULL
§	NULL
&	NULL
0	NULL
«	NULL
$	NULL
732.61	NULL
>	NULL
%	NULL
4	NULL
%	NULL
*	NULL
``	NULL
4	NULL
9	NULL
``	NULL
Q1	NULL
7.07331	NULL
}	NULL
<	NULL
4	NULL
Q9	NULL
,	NULL
zﬁﬁﬁ	NULL
$	NULL
1ng	NULL
100	NULL
C33	NULL
,	NULL
cervical	NULL
carcinoma	NULL
,	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
&	NULL
3	NULL
e	NULL
<	NULL
E	NULL
a	NULL
50	NULL
§	NULL
a	NULL
0	NULL
QpV	NULL
’	NULL
)	NULL
‘	NULL
l	NULL
‘	NULL
l	NULL
?	NULL

‘	NULL
mb	NULL
‘	NULL
7	NULL
‘	NULL
J	NULL
422	NULL
to	NULL
0	NULL
0	NULL
,	NULL
4.2	NULL
.	NULL

``	NULL
%	NULL
*	NULL
,	NULL
4	NULL
,	NULL
YP	NULL
?	NULL

9p	NULL
1p	NULL
1p	NULL
Ap	NULL
p	NULL
Fp	NULL
Ip	NULL
1D	NULL
100	NULL
10T1/2	NULL
,	NULL
fibroblasts	NULL
,	NULL
od4	NULL
(	NULL
-	NULL
)	NULL
50	NULL
Relative	NULL
CAT	NULL
Activity	NULL
100	NULL
C2C12	NULL
,	NULL
myoblasts	NULL
,	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
Relative	NULL
CAT	NULL
Activity	NULL
U	NULL
a	NULL
C	NULL
Jurkat	NULL
,	NULL
T	NULL
cell	NULL
line	NULL
,	NULL
(	NULL
4	NULL
(	NULL
+	NULL
)	NULL
100	NULL
z	NULL
a	NULL
§	NULL
4	NULL
I	NULL
;	NULL
50	NULL
O	NULL
F	NULL
-l	NULL
e	NULL
C	NULL
a	NULL
0	NULL
ay	NULL
5	NULL
2	NULL
Cp	NULL
o.	NULL
N	NULL
54	NULL
,	NULL
2	NULL
poé	NULL
%	NULL
¢	NULL
%	NULL
d	NULL
%	NULL
%	NULL
o	NULL
%	NULL
4	NULL
,	NULL
79	NULL
?	NULL

10	NULL
177	NULL
D	NULL
lp	NULL
1p	NULL
F	NULL
HEL	NULL
,	NULL
erythroleukemia	NULL
,	NULL
04	NULL
(	NULL
+	NULL
)	NULL
Relative	NULL
CAT	NULL
Activity	NULL
w	NULL
=	NULL
J	NULL
&	NULL
&	NULL
tence	NULL
4	NULL
%	NULL
.	NULL

4	NULL
a	NULL
n.	NULL
4	NULL
09	NULL
.	NULL

I	NULL
.	NULL
``	NULL

oC	NULL
I4	NULL
giv	NULL
}	NULL
1i	NULL
%	NULL
?	NULL

1ft	NULL
%	NULL
ﬁgﬁ	NULL
%	NULL
z	NULL
%	NULL
zgzqz	NULL
T	NULL
Raji	NULL
,	NULL
B	NULL
cell	NULL
line	NULL
,	NULL
04	NULL
(	NULL
+	NULL
)	NULL
100	NULL
Relative	NULL
CAT	NULL
Activity	NULL
tn	NULL
&	NULL
r	NULL
rae	NULL
a	NULL
4	NULL
g	NULL
g	NULL
49	NULL
``	NULL
p	NULL
Toe	NULL
``	NULL
o	NULL
**	NULL
46	NULL
»	NULL
?	NULL

1312	NULL
1p	NULL
1p	NULL
1p	NULL
pnp	NULL
p	NULL
C€2C12	NULL
,	NULL
myotubes	NULL
,	NULL
04	NULL
(	NULL
+	NULL
)	NULL
Relative	NULL
CAT	NULL
Activity	NULL
#	NULL
5	NULL
©	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

04	NULL
gene	NULL
promoter	NULL
activity	NULL
is	NULL
under	NULL
negative	NULL
regulation	NULL
in	NULL
G4	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
04	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
.	NULL

Numbers	NULL
in	NULL
the	NULL
construct	NULL
name	NULL
indicate	NULL
the	NULL
position	NULL
in	NULL
the	NULL
flanking	NULL
sequences	NULL
.	NULL

Cells	NULL
were	NULL
transfected	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
duplicate	NULL
assays	NULL
and	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

For	NULL
transfection	NULL
in	NULL
C2C12	NULL
myotubes	NULL
,	NULL
C2C12	NULL
myoblast	NULL
cells	NULL
were	NULL
switched	NULL
to	NULL
media	NULL
containing	NULL
2	NULL
%	NULL
horse	NULL
serum	NULL
and	NULL
maintained	NULL
for	NULL
4	NULL
days	NULL
before	NULL
harvesting	NULL
for	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
as	NULL
described	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

during	NULL
myogenic	NULL
differentiation	NULL
(	NULL
Figure	NULL
4C	NULL
,	NULL
and	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Overexpression	NULL
of	NULL
the	NULL
bHLH	NULL
E	NULL
proteins	NULL
E12	NULL
and	NULL
E47	NULL
did	NULL
not	NULL
have	NULL
any	NULL
effect	NULL
on	NULL
repression	NULL
by	NULL
ZEB	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
,	NULL
further	NULL
suggesting	NULL
that	NULL
bHLH	NULL
proteins	NULL
do	NULL
not	NULL
displace	NULL
ZEB	NULL
in	NULL
hematopoietic	NULL
cells	NULL
as	NULL
they	NULL
do	NULL
in	NULL
muscle	NULL
cells	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
c-Myb	NULL
is	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
to	NULL
overcome	NULL
repression	NULL
by	NULL
ZEB	NULL
The	NULL
results	NULL
described	NULL
above	NULL
suggest	NULL
that	NULL
a	NULL
hematopoietic-specific	NULL
transcription	NULL
factor	NULL
may	NULL
overcome	NULL
ZEB	NULL
repression	NULL
3926	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
4	NULL
gene	NULL
promoter	NULL
.	NULL

c-Myb	NULL
is	NULL
one	NULL
of	NULL
the	NULL
first	NULL
transcription	NULL
factors	NULL
detected	NULL
during	NULL
hematopoiesis	NULL
,	NULL
where	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
differentiation	NULL
process	NULL
(	NULL
reviewed	NULL
in	NULL
Graf	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
c-Myb	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
synergize	NULL
with	NULL
Ets	NULL
factors	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
hematopoietic	NULL
genes	NULL
.	NULL

The	NULL
early	NULL
appearance	NULL
of	NULL
oA	NULL
during	NULL
hematopoiesis	NULL
suggests	NULL
that	NULL
od	NULL
expression	NULL
is	NULL
likely	NULL
to	NULL
depend	NULL
upon	NULL
a	NULL
transcription	NULL
factor	NULL
such	NULL
as	NULL
c-Myb	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
number	NULL
of	NULL
potential	NULL
c-Myb	NULL
sites	NULL
are	NULL
evident	NULL
upstream	NULL
and	NULL
downstream	NULL
of	NULL
the	NULL
ZEB	NULL
sites	NULL
(	NULL
from	NULL
-130	NULL
bp	NULL
to	NULL
-2.0	NULL
kb	NULL
)	NULL
in	NULL
the	NULL
oé4	NULL
promoter	NULL
(	NULL
Figure	NULL
5A	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Gel-shift	NULL
experiments	NULL
demonstrated	NULL
that	NULL
B	NULL
Lymphoid	NULL
cells	NULL
-2.0	NULL
®	NULL
16	NULL
(	NULL
Ets	NULL
)	NULL
20	NULL
10	NULL
%	NULL
chloramphenicol	NULL
acetylated	NULL
C	NULL
Myotubes	NULL
%	NULL
chloramphenicol	NULL
acetylated	NULL
o	NULL
s	NULL
S3	NULL
49,0	NULL
*	NULL
,	NULL
*	NULL
%	NULL
%	NULL
”	NULL
o	NULL
f000	NULL
T	NULL
1p	NULL
»	NULL
Tp	NULL
Xe	NULL
Xe	NULL
2	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Lymphoid	NULL
cells	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
ZEB	NULL
mRNA	NULL
and	NULL
overexpression	NULL
of	NULL
ZEB	NULL
does	NULL
not	NULL
silence	NULL
4	NULL
promoter	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
mRNA	NULL
levels	NULL
for	NULL
ZEB	NULL
in	NULL
04	NULL
(	NULL
-	NULL
)	NULL
C2C12	NULL
myoblasts	NULL
,	NULL
G4	NULL
(	NULL
-	NULL
)	NULL
HT1080	NULL
fibrosarcoma	NULL
cells	NULL
and	NULL
4	NULL
(	NULL
+	NULL
)	NULL
T-lymphoid	NULL
Jurkat	NULL
cells	NULL
were	NULL
determined	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
using	NULL
a	NULL
NIeI-HindIlH	NULL
fragment	NULL
of	NULL
ZEB	NULL
cDNA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Overexpression	NULL
of	NULL
ZEB	NULL
in	NULL
G4	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
lymphoid	NULL
cells	NULL
does	NULL
not	NULL
silence	NULL
04	NULL
promoter	NULL
activity	NULL
.	NULL

Twenty-five	NULL
ug	NULL
of	NULL
ACAT	NULL
reporter	NULL
constructs	NULL
were	NULL
co-transfected	NULL
with	NULL
60	NULL
pug	NULL
of	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
ZEB	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
erythroleukemia	NULL
cell	NULL
line	NULL
HEL	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Overexpression	NULL
of	NULL
ZEB	NULL
in	NULL
G4	NULL
(	NULL
+	NULL
)	NULL
C2C12	NULL
myotubes	NULL
represses	NULL
4	NULL
gene	NULL
promoter	NULL
activity	NULL
and	NULL
restores	NULL
silencer	NULL
activity	NULL
.	NULL

C2C12	NULL
myoblasts	NULL
were	NULL
transfected	NULL
with	NULL
8	NULL
ug	NULL
of	NULL
QACAT	NULL
reporters	NULL
and	NULL
12	NULL
ug	NULL
of	NULL
ZEB	NULL
and	NULL
stimulated	NULL
to	NULL
fuse	NULL
into	NULL
myotubes	NULL
as	NULL
in	NULL
Figure	NULL
1.	NULL
some	NULL
of	NULL
these	NULL
sites	NULL
bind	NULL
efficiently	NULL
to	NULL
recombinant	NULL
c-Myb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
-130	NULL
to	NULL
400	NULL
region	NULL
as	NULL
well	NULL
as	NULL
individual	NULL
sites	NULL
in	NULL
the	NULL
04	NULL
promoter	NULL
were	NULL
tested	NULL
c-Myb/Ets	NULL
overcome	NULL
ZEB	NULL
repression	NULL
A	NULL
B	NULL
LJ	NULL
-USF-	NULL
-	NULL
kth4a	NULL
im	NULL
\USF	NULL
-IEB-	NULL
-	NULL
b	NULL
}	NULL
{	NULL
bab4t	NULL
-	NULL
HHM	NULL
)	NULL
|	NULL
Probe	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

ZEB	NULL
binds	NULL
ZEB	NULL
sites	NULL
in	NULL
both	NULL
G4	NULL
(	NULL
-	NULL
)	NULL
and	NULL
4	NULL
(	NULL
+	NULL
)	NULL
cells	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
using	NULL
a	NULL
probe	NULL
containing	NULL
ZEB	NULL
sites	NULL
E361	NULL
and	NULL
E399	NULL
from	NULL
the	NULL
G4	NULL
promoter	NULL
gave	NULL
a	NULL
similar	NULL
pattern	NULL
of	NULL
binding	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
04	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
and	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
HT1080	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Antibodies	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
against	NULL
ZEB	NULL
,	NULL
USF	NULL
,	NULL
E12	NULL
,	NULL
HEB	NULL
(	NULL
this	NULL
figure	NULL
)	NULL
and	NULL
MyoD	NULL
and	NULL
c-Myb	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
were	NULL
added	NULL
in	NULL
the	NULL
binding	NULL
assays	NULL
.	NULL

Only	NULL
ZEB	NULL
and	NULL
USF	NULL
show	NULL
binding	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
supershift	NULL
of	NULL
the	NULL
corresponding	NULL
bands	NULL
(	NULL
indicated	NULL
as	NULL
*	NULL
)	NULL
.	NULL

'NS	NULL
'	NULL
indicates	NULL
non-specific	NULL
complexes	NULL
.	NULL

ZEB	NULL
and	NULL
USF	NULL
binding	NULL
was	NULL
competed	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
,	NULL
but	NULL
not	NULL
with	NULL
the	NULL
corresponding	NULL
mutant	NULL
probe	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

for	NULL
c-Myb	NULL
binding	NULL
with	NULL
nuclear	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
(	NULL
Figure	NULL
5A	NULL
and	NULL
B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Binding	NULL
was	NULL
evident	NULL
with	NULL
extracts	NULL
from	NULL
Jurkat	NULL
cells	NULL
but	NULL
not	NULL
with	NULL
extracts	NULL
from	NULL
the	NULL
control	NULL
4	NULL
(	NULL
-	NULL
)	NULL
/c-myb	NULL
(	NULL
-	NULL
)	NULL
fibrosarcoma	NULL
cell	NULL
line	NULL
HT1O80	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

This	NULL
binding	NULL
was	NULL
blocked	NULL
by	NULL
unlabeled	NULL
c-Myb	NULL
sites	NULL
from	NULL
the	NULL
04	NULL
gene	NULL
promoter	NULL
and	NULL
other	NULL
genes	NULL
regulated	NULL
by	NULL
c-Myb	NULL
[	NULL
such	NULL
as	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
8	NULL
enhancer	NULL
(	NULL
Hernandez-Munain	NULL
and	NULL
Krangel	NULL
,	NULL
1994	NULL
)	NULL
]	NULL
,	NULL
but	NULL
not	NULL
by	NULL
their	NULL
corresponding	NULL
mutated	NULL
sites	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
binding	NULL
was	NULL
inhibited	NULL
by	NULL
anti-c-Myb	NULL
antibodies	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
c-Myb	NULL
was	NULL
sufficient	NULL
to	NULL
activate	NULL
the	NULL
oA	NULL
gene	NULL
promoter	NULL
in	NULL
o4	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
,	NULL
an	NULL
expression	NULL
vector	NULL
for	NULL
c-Myb	NULL
was	NULL
co-transfected	NULL
with	NULL
oA	NULL
gene	NULL
promoter	NULL
constructs	NULL
into	NULL
the	NULL
4	NULL
(	NULL
-	NULL
)	NULL
/c-myb	NULL
(	NULL
-	NULL
)	NULL
HTIO8O	NULL
fibrosarcoma	NULL
cells	NULL
.	NULL

c-Myb	NULL
overcame	NULL
the	NULL
repressor	NULL
activity	NULL
of	NULL
ZEB	NULL
and	NULL
activated	NULL
the	NULL
oé4	NULL
gene	NULL
promoter	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Reporter	NULL
constructs	NULL
containing	NULL
different	NULL
combinations	NULL
of	NULL
Ets	NULL
sites	NULL
,	NULL
ZEB	NULL
sites	NULL
and	NULL
c-Myb	NULL
sites	NULL
were	NULL
then	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
[	NULL
as	NULL
well	NULL
as	NULL
04	NULL
(	NULL
-	NULL
)	NULL
HTIO8O	NULL
cells	NULL
]	NULL
(	NULL
Figure	NULL
6A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
ZEB	NULL
sites	NULL
in	NULL
Jurkat	NULL
cells	NULL
was	NULL
blocked	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
Ets	NULL
and	NULL
c-Myb	NULL
sites	NULL
;	NULL
however	NULL
,	NULL
mutation	NULL
of	NULL
either	NULL
the	NULL
Ets	NULL
or	NULL
c-Myb	NULL
sites	NULL
restored	NULL
repressor	NULL
activity	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
the	NULL
requirement	NULL
for	NULL
both	NULL
Ets	NULL
and	NULL
c-Myb	NULL
sites	NULL
to	NULL
overcome	NULL
repression	NULL
by	NULL
ZEB	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
note	NULL
that	NULL
addition	NULL
of	NULL
the	NULL
c-Myb	NULL
sites	NULL
to	NULL
the	NULL
Ets	NULL
sites	NULL
did	NULL
not	NULL
change	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
significantly	NULL
above	NULL
that	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
alone	NULL
.	NULL

Therefore	NULL
,	NULL
c-Myb	NULL
does	NULL
not	NULL
overcome	NULL
ZEB	NULL
repression	NULL
by	NULL
increasing	NULL
transcription	NULL
when	NULL
combined	NULL
with	NULL
Ets	NULL
factors	NULL
and	NULL
simply	NULL
overwhelming	NULL
repression	NULL
by	NULL
ZEB	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
c-Myb	NULL
and	NULL
Ets	NULL
activates	NULL
transcription	NULL
through	NULL
a	NULL
mechanism	NULL
distinct	NULL
from	NULL
either	NULL
factor	NULL
alone	NULL
and	NULL
in	NULL
a	NULL
fashion	NULL
resistant	NULL
to	NULL
ZEB	NULL
.	NULL

ZEB	NULL
fused	NULL
to	NULL
the	NULL
DNA-binding	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
of	NULL
the	NULL
yeast	NULL
protein	NULL
Gal4	NULL
blocked	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
,	NULL
demonstrating	NULL
directly	NULL
that	NULL
ZEB	NULL
blocks	NULL
Ets	NULL
transactivation	NULL
.	NULL

Additionally	NULL
,	NULL
ZEB	NULL
fused	NULL
to	NULL
the	NULL
DBD	NULL
of	NULL
the	NULL
bacterial	NULL
protein	NULL
LexA	NULL
blocked	NULL
transactivation	NULL
by	NULL
3927	NULL
A.A.Postigo	NULL
et	NULL
al	NULL
.	NULL

A	NULL
04	NULL
(	NULL
+	NULL
)	NULL
hematopoietic	NULL
cells	NULL
%	NULL
chloramphenicol	NULL
acetylated	NULL
ju	NULL
&	NULL
~	NULL
6	NULL
On	NULL
Or	NULL
%	NULL
00	NULL
Cy	NULL
Uy	NULL
Up	NULL
Ap	NULL
A	NULL
r	NULL
,	NULL
&	NULL
‘	NULL
éyx	NULL
r	NULL
*	NULL
p	NULL
4	NULL
4	NULL
4	NULL
,	NULL
4	NULL
x	NULL
x0	NULL
67	NULL
>	NULL
``	NULL
:	NULL
B	NULL
ad	NULL
(	NULL
-	NULL
cells	NULL
2	NULL
20	NULL
20	NULL
a	NULL
}	NULL
i	NULL
i	NULL
10	NULL
0	NULL
|	NULL
0	NULL
}	NULL
0	NULL
C	NULL
04	NULL
(	NULL
+	NULL
)	NULL
myotubes	NULL
16	NULL
|	NULL
ZEB	NULL
site	NULL
|	NULL
3b	NULL
3	NULL
2	NULL
4	NULL
.	NULL

C	NULL
3	NULL
G	NULL
5	NULL
Or	NULL
,	NULL
C	NULL
6	NULL
6	NULL
‘	NULL
0	NULL
©	NULL
*C	NULL
Crypt	NULL
»	NULL
A	NULL
Q	NULL
’	NULL
z	NULL
’	NULL
g	NULL
,	NULL
``	NULL
6333	NULL
‘	NULL
06	NULL
‘	NULL
299	NULL
P.	NULL
3	NULL
%	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

ZEB	NULL
sites	NULL
are	NULL
silencers	NULL
in	NULL
04	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
when	NULL
taken	NULL
out	NULL
of	NULL
the	NULL
context	NULL
of	NULL
the	NULL
04	NULL
gene	NULL
promoter	NULL
.	NULL

E361	NULL
and	NULL
E399	NULL
ZEB	NULL
binding	NULL
sites	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
(	NULL
4	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
-7604CAT	NULL
,	NULL
and	NULL
the	NULL
resulting	NULL
constructs	NULL
were	NULL
transfected	NULL
in	NULL
04	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
.	NULL

Repressor	NULL
activity	NULL
was	NULL
found	NULL
in	NULL
G4	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
(	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
the	NULL
erythroleukemia	NULL
HEL	NULL
cell	NULL
line	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
04	NULL
(	NULL
-	NULL
)	NULL
HT1080	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
but	NULL
not	NULL
in	NULL
G4	NULL
(	NULL
+	NULL
)	NULL
C2C12	NULL
myotubes	NULL
(	NULL
C	NULL
)	NULL
.	NULL

The	NULL
control	NULL
E	NULL
box	NULL
at	NULL
-585	NULL
bp	NULL
which	NULL
is	NULL
not	NULL
a	NULL
ZEB	NULL
site	NULL
did	NULL
not	NULL
repress	NULL
Ets	NULL
activity	NULL
.	NULL

Overexpression	NULL
of	NULL
the	NULL
bHLH	NULL
E	NULL
proteins	NULL
E12	NULL
and	NULL
E47	NULL
in	NULL
Jurkat	NULL
cells	NULL
did	NULL
not	NULL
block	NULL
repression	NULL
by	NULL
ZEB	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Twenty	NULL
five	NULL
ug	NULL
of	NULL
(	NULL
ACAT	NULL
reporter	NULL
constructs	NULL
were	NULL
co-transfected	NULL
in	NULL
Jurkat	NULL
with	NULL
or	NULL
without	NULL
60	NULL
ug	NULL
of	NULL
E12	NULL
or	NULL
E47	NULL
expression	NULL
vectors	NULL
.	NULL

In	NULL
HT1O80	NULL
cells	NULL
and	NULL
C2C12	NULL
myotubes	NULL
,	NULL
3	NULL
pig	NULL
of	NULL
the	NULL
reporter	NULL
constructs	NULL
were	NULL
transfected	NULL
.	NULL

c-Myb	NULL
fused	NULL
to	NULL
the	NULL
DBD	NULL
of	NULL
Gal4	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
ZEB	NULL
blocks	NULL
the	NULL
transactivation	NULL
domain	NULL
of	NULL
c-Myb	NULL
.	NULL

Thefore	NULL
,	NULL
ZEB	NULL
blocks	NULL
the	NULL
transactivation	NULL
activity	NULL
of	NULL
Ets	NULL
and	NULL
c-Myb	NULL
individually	NULL
,	NULL
but	NULL
the	NULL
combination	NULL
of	NULL
these	NULL
sites	NULL
synergistically	NULL
overcomes	NULL
the	NULL
repression	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
expression	NULL
of	NULL
c-Myb	NULL
is	NULL
an	NULL
important	NULL
determining	NULL
factor	NULL
in	NULL
the	NULL
control	NULL
(	NULL
4	NULL
expression	NULL
in	NULL
hematopoetic	NULL
cells	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
conclusion	NULL
,	NULL
forced	NULL
expression	NULL
of	NULL
c-Myb	NULL
in	NULL
04	NULL
(	NULL
-	NULL
)	NULL
/c-myb	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
led	NULL
to	NULL
expression	NULL
of	NULL
endogenous	NULL
04	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

As	NULL
another	NULL
way	NULL
of	NULL
demonstrating	NULL
an	NULL
important	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
(	NULL
4	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
used	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
c-Myb	NULL
(	NULL
MT	NULL
)	NULL
that	NULL
contains	NULL
the	NULL
DBD	NULL
of	NULL
c-Myb	NULL
but	NULL
lacks	NULL
the	NULL
transactivation	NULL
domain	NULL
(	NULL
Badiani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

This	NULL
dominant-negative	NULL
c-Myb	NULL
has	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
block	NULL
c-Myb	NULL
function	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
(	NULL
Badiani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Taylor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Co-transfection	NULL
of	NULL
the	NULL
MT	NULL
expression	NULL
vector	NULL
with	NULL
the	NULL
-2.00A4CAT	NULL
reporter	NULL
in	NULL
Jurkat	NULL
cells	NULL
repressed	NULL
the	NULL
activity	NULL
of	NULL
-2.004CAT	NULL
to	NULL
a	NULL
level	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
04	NULL
(	NULL
-	NULL
)	NULL
HT1O80	NULL
cells	NULL
(	NULL
Figure	NULL
8A	NULL
)	NULL
.	NULL

These	NULL
results	NULL
provide	NULL
additional	NULL
evidence	NULL
that	NULL
c-Myb	NULL
is	NULL
required	NULL
for	NULL
(	NULL
4	NULL
gene	NULL
promoter	NULL
activity	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Loss	NULL
of	NULL
(	NULL
4	NULL
expression	NULL
on	NULL
hematopoietic	NULL
progenitors	NULL
in	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
die	NULL
in	NULL
utero	NULL
due	NULL
to	NULL
severe	NULL
anemia	NULL
,	NULL
showing	NULL
a	NULL
reduced	NULL
number	NULL
of	NULL
hematopoietic	NULL
precursors	NULL
in	NULL
the	NULL
liver	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
expression	NULL
of	NULL
4	NULL
integrin	NULL
on	NULL
hematopoietic	NULL
cells	NULL
in	NULL
embryonic	NULL
day	NULL
14.5	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
.	NULL

If	NULL
c-Myb	NULL
is	NULL
indeed	NULL
important	NULL
for	NULL
expression	NULL
of	NULL
04	NULL
,	NULL
then	NULL
(	NULL
4	NULL
should	NULL
be	NULL
absent	NULL
from	NULL
hematopoietic	NULL
cells	NULL
in	NULL
these	NULL
mice	NULL
.	NULL

We	NULL
found	NULL
that	NULL
expression	NULL
of	NULL
04	NULL
integrin	NULL
in	NULL
the	NULL
hematopoietic	NULL
cell	NULL
pro	NULL
3928	NULL
genitors	NULL
present	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
was	NULL
abrogated	NULL
in	NULL
the	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
(	NULL
Figure	NULL
8B	NULL
)	NULL
,	NULL
but	NULL
was	NULL
high	NULL
in	NULL
c-myb	NULL
(	NULL
+/	NULL
+	NULL
)	NULL
mice	NULL
(	NULL
Figure	NULL
8C	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
in	NULL
vivo	NULL
expression	NULL
of	NULL
04	NULL
requires	NULL
c-Myb	NULL
.	NULL

As	NULL
controls	NULL
,	NULL
expression	NULL
of	NULL
other	NULL
markers	NULL
seemed	NULL
to	NULL
be	NULL
unaffected	NULL
in	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
G4	NULL
in	NULL
other	NULL
tissues	NULL
such	NULL
as	NULL
skeletal	NULL
and	NULL
smooth	NULL
muscle	NULL
and	NULL
neural	NULL
crest	NULL
derivatives	NULL
was	NULL
similar	NULL
in	NULL
both	NULL
the	NULL
(	NULL
-/-	NULL
)	NULL
and	NULL
(	NULL
+/+	NULL
)	NULL
genotypes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
indicating	NULL
a	NULL
selective	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
the	NULL
expression	NULL
of	NULL
4	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
a	NULL
key	NULL
role	NULL
for	NULL
c-Myb	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
oA	NULL
gene	NULL
,	NULL
and	NULL
place	NULL
04	NULL
as	NULL
one	NULL
of	NULL
the	NULL
first	NULL
genes	NULL
demonstrated	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
c-Myb	NULL
in	NULL
vivo	NULL
.	NULL

Discussion	NULL
ZEB	NULL
is	NULL
a	NULL
vertebrate	NULL
homolog	NULL
of	NULL
the	NULL
Drosophila	NULL
Zfh-1	NULL
protein	NULL
.	NULL

Zfh-1	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
in	NULL
differentiation	NULL
of	NULL
tissues	NULL
such	NULL
as	NULL
the	NULL
CNS	NULL
and	NULL
muscle	NULL
in	NULL
Drosophila	NULL
(	NULL
Fortini	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Lai	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

We	NULL
have	NULL
found	NULL
previously	NULL
that	NULL
ZEB	NULL
is	NULL
an	NULL
active	NULL
transcriptional	NULL
repressor	NULL
that	NULL
,	NULL
like	NULL
Zfh-1	NULL
,	NULL
regulates	NULL
muscle	NULL
differentiation	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

ZEB	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
other	NULL
tissues	NULL
,	NULL
and	NULL
we	NULL
present	NULL
evidence	NULL
here	NULL
that	NULL
it	NULL
may	NULL
also	NULL
have	NULL
a	NULL
regulatory	NULL
role	NULL
in	NULL
hematopoiesis	NULL
.	NULL

Both	NULL
c-Myb	NULL
and	NULL
Ets	NULL
are	NULL
required	NULL
for	NULL
normal	NULL
hematopoiesis	NULL
(	NULL
Shivdasani	NULL
and	NULL
Orkin	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

These	NULL
factors	NULL
can	NULL
act	NULL
in	NULL
synergy	NULL
to	NULL
activate	NULL
transcription	NULL
,	NULL
and	NULL
this	NULL
synergy	NULL
is	NULL
essential	NULL
for	NULL
activation	NULL
of	NULL
important	NULL
hematopoietic	NULL
genes	NULL
(	NULL
reviewed	NULL
in	NULL
Graf	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

ZEB	NULL
blocks	NULL
the	NULL
activity	NULL
of	NULL
Ets	NULL
and	NULL
Myb	NULL
individually	NULL
,	NULL
but	NULL
repressor	NULL
activity	NULL
is	NULL
overcome	NULL
by	NULL
the	NULL
c-Myb/Ets	NULL
synergy	NULL
.	NULL

ZEB	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
4	NULL
integrin	NULL
gene	NULL
render	NULL
expression	NULL
dependent	NULL
upon	NULL
the	NULL
synergy	NULL
between	NULL
c-Myb	NULL
and	NULL
Ets	NULL
and	NULL
may	NULL
provide	NULL
a	NULL
explanation	NULL
for	NULL
why	NULL
this	NULL
synergy	NULL
A	NULL
Hﬂi	NULL
t	NULL
Id'iﬁf	NULL
t	NULL
__	NULL
if	NULL
?	NULL

”	NULL
©4	NULL
(	NULL
+	NULL
)	NULL
lymphocytes	NULL
-	NULL
04	NULL
(	NULL
-	NULL
)	NULL
&	NULL
°	NULL
Fou	NULL
o	NULL
.g	NULL
&	NULL
Competitor	NULL
Q	NULL
‘	NULL
c—N'héﬁé	NULL
’	NULL
b	NULL
—	NULL
@	NULL
$	NULL
|	NULL
f	NULL
USF-	NULL
,	NULL
r	NULL
|	NULL
n	NULL
ZEB~-	NULL
||	NULL
ns-	NULL
|	NULL
biMbL	NULL
’	NULL
{	NULL
probe	NULL
-	NULL
m	NULL
B	NULL
<	NULL
4	NULL
=	NULL
]	NULL
2	NULL
§	NULL
4	NULL
4	NULL
a	NULL
5	NULL
5	NULL
x	NULL
t	NULL
t	NULL
to	NULL
to	NULL
3	NULL
A	NULL
A	NULL
a	NULL
m	NULL
``	NULL
3	NULL
fog	NULL
VL	NULL
aa	NULL
3	NULL
T	NULL
20	NULL
Competitor	NULL
a	NULL
.	NULL

2	NULL
E	NULL
E	NULL
BE	NULL
6	NULL
4	NULL
myb	NULL
--	NULL
l	NULL
Wik	NULL
Probe	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

The	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
c-Myb	NULL
binds	NULL
to	NULL
the	NULL
04	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
A	NULL
number	NULL
of	NULL
c-Myb	NULL
sites	NULL
are	NULL
evident	NULL
in	NULL
the	NULL
G4	NULL
promoter	NULL
between	NULL
-130	NULL
bp	NULL
and	NULL
-2.0	NULL
kb	NULL
(	NULL
this	NULL
figure	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
arrows	NULL
on	NULL
the	NULL
top	NULL
indicate	NULL
c-Myb	NULL
sites	NULL
,	NULL
whereas	NULL
arrows	NULL
on	NULL
the	NULL
bottom	NULL
indicate	NULL
the	NULL
ZEB	NULL
sites	NULL
)	NULL
.	NULL

Gel	NULL
retardation	NULL
assay	NULL
using	NULL
as	NULL
a	NULL
probe	NULL
from	NULL
-130	NULL
to	NULL
-400	NULL
of	NULL
the	NULL
G4	NULL
gene	NULL
promoter	NULL
shows	NULL
the	NULL
binding	NULL
of	NULL
c-Myb	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
G4	NULL
(	NULL
+	NULL
)	NULL
lymphoid	NULL
cell	NULL
line	NULL
Jurkat	NULL
but	NULL
not	NULL
from	NULL
04	NULL
(	NULL
-	NULL
)	NULL
HT1080	NULL
fibrosarcoma	NULL
cells	NULL
,	NULL
as	NULL
evidenced	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
containing	NULL
a	NULL
consensus	NULL
c-Myb	NULL
sequence	NULL
.	NULL

'NS	NULL
'	NULL
indicates	NULL
non-specific	NULL
complexes	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Gel	NULL
retardation	NULL
assay	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
04	NULL
(	NULL
+	NULL
)	NULL
/c-myb	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
and	NULL
the	NULL
c-Myb	NULL
site	NULL
at	NULL
position	NULL
-134	NULL
bp	NULL
of	NULL
the	NULL
04	NULL
gene	NULL
promoter	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

'Competitor®	NULL
'	NULL
indicates	NULL
addition	NULL
to	NULL
the	NULL
binding	NULL
reaction	NULL
of	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
wild-type	NULL
and	NULL
mutant	NULL
(	NULL
mut	NULL
)	NULL
c-Myb	NULL
sites	NULL
from	NULL
the	NULL
4	NULL
gene	NULL
(	NULL
-134	NULL
)	NULL
or	NULL
the	NULL
TCR	NULL
&	NULL
enhancer	NULL
[	NULL
8EB3	NULL
(	NULL
3	NULL
'	NULL
)	NULL
,	NULL
Hernandez-Munain	NULL
and	NULL
Krangel	NULL
,	NULL
1994	NULL
]	NULL
.	NULL

'NS	NULL
'	NULL
indicates	NULL
non-specific	NULL
complexes	NULL
.	NULL

is	NULL
required	NULL
.	NULL

During	NULL
differentiation	NULL
and	NULL
cell	NULL
activation	NULL
,	NULL
the	NULL
level	NULL
of	NULL
c-Myb	NULL
varies	NULL
and	NULL
,	NULL
when	NULL
it	NULL
is	NULL
expressed	NULL
,	NULL
it	NULL
synergizes	NULL
with	NULL
Ets	NULL
factors	NULL
to	NULL
overcome	NULL
ZEB	NULL
repression	NULL
and	NULL
activate	NULL
hematopoietic	NULL
genes	NULL
.	NULL

We	NULL
presented	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
evidence	NULL
that	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
c-Myb	NULL
,	NULL
ZEB	NULL
c-Myb/Ets	NULL
overcome	NULL
ZEB	NULL
repression	NULL
blocks	NULL
oA	NULL
expression	NULL
throughout	NULL
all	NULL
hematopoietic	NULL
cell	NULL
lineages	NULL
.	NULL

Conversely	NULL
,	NULL
we	NULL
found	NULL
that	NULL
without	NULL
ZEB	NULL
,	NULL
the	NULL
o4	NULL
gene	NULL
would	NULL
be	NULL
expressed	NULL
constitutively	NULL
as	NULL
a	NULL
result	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
.	NULL

This	NULL
mechanism	NULL
of	NULL
regulating	NULL
ZEB	NULL
activity	NULL
and	NULL
4	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
is	NULL
different	NULL
from	NULL
what	NULL
we	NULL
found	NULL
previously	NULL
in	NULL
muscle	NULL
cells	NULL
,	NULL
where	NULL
ZEB	NULL
is	NULL
displaced	NULL
from	NULL
ZEB	NULL
sites	NULL
by	NULL
myogenic	NULL
bHLH	NULL
factors	NULL
that	NULL
appear	NULL
during	NULL
myogenic	NULL
differentiation	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

During	NULL
development	NULL
,	NULL
initial	NULL
hematopoiesis	NULL
takes	NULL
place	NULL
in	NULL
the	NULL
yolk	NULL
sac	NULL
(	NULL
or	NULL
analogs	NULL
in	NULL
mammalians	NULL
)	NULL
and	NULL
paraortic	NULL
compartments	NULL
(	NULL
reviewed	NULL
in	NULL
Dorshkind	NULL
,	NULL
1994	NULL
;	NULL
Orkin	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Hematopoietic	NULL
stem	NULL
cells	NULL
migrate	NULL
from	NULL
those	NULL
sites	NULL
to	NULL
the	NULL
fetal	NULL
liver	NULL
of	NULL
the	NULL
embryo	NULL
where	NULL
most	NULL
of	NULL
the	NULL
embryonic	NULL
hematopoiesis	NULL
occurs	NULL
.	NULL

Perinatally	NULL
,	NULL
stem	NULL
cells	NULL
migrate	NULL
to	NULL
the	NULL
thymus	NULL
and	NULL
bone	NULL
marrow	NULL
.	NULL

Recently	NULL
,	NULL
chimeric	NULL
animal	NULL
experiments	NULL
have	NULL
shown	NULL
that	NULL
B1	NULL
integrins	NULL
(	NULL
a	NULL
larger	NULL
subclass	NULL
of	NULL
integrins	NULL
including	NULL
(	NULL
41	NULL
)	NULL
are	NULL
involved	NULL
in	NULL
this	NULL
migration	NULL
process	NULL
(	NULL
Hirscht	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Hematopoiesis	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
,	NULL
thymus	NULL
and	NULL
bone	NULL
marrow	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
adhesion	NULL
molecules	NULL
on	NULL
the	NULL
stem	NULL
cells	NULL
with	NULL
ligands	NULL
in	NULL
stromal	NULL
cells	NULL
.	NULL

One	NULL
of	NULL
the	NULL
interactions	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
to	NULL
be	NULL
crucial	NULL
for	NULL
normal	NULL
hematopoietic	NULL
development	NULL
is	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
4	NULL
integrin	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
stem	NULL
cells	NULL
to	NULL
its	NULL
ligands	NULL
VCAM-1	NULL
and	NULL
fibronectin	NULL
in	NULL
the	NULL
stroma	NULL
of	NULL
these	NULL
organs	NULL
(	NULL
Miyake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Roldan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

o4	NULL
appears	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
precursor	NULL
cells	NULL
very	NULL
early	NULL
during	NULL
hematopoiesis	NULL
,	NULL
before	NULL
most	NULL
lineage-specific	NULL
markers	NULL
(	NULL
Sanchez	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
04	NULL
and	NULL
VCAM-1	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
differentiation	NULL
of	NULL
cultured	NULL
precursors	NULL
(	NULL
Miyake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Roldan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Teixido	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Likewise	NULL
,	NULL
injection	NULL
of	NULL
anti-o4	NULL
antibodies	NULL
into	NULL
pregnant	NULL
mice	NULL
blocked	NULL
erythropoiesis	NULL
and	NULL
inhibited	NULL
other	NULL
lineages	NULL
in	NULL
the	NULL
embryos	NULL
(	NULL
Hamamura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
in	NULL
mice	NULL
chimeric	NULL
for	NULL
(	NULL
4	NULL
that	NULL
this	NULL
integrin	NULL
is	NULL
required	NULL
for	NULL
lymphoid	NULL
differentiation	NULL
in	NULL
the	NULL
bone	NULL
marrow	NULL
(	NULL
Arroyo	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
c-myb	NULL
gene	NULL
causes	NULL
mice	NULL
to	NULL
die	NULL
in	NULL
utero	NULL
due	NULL
to	NULL
a	NULL
failure	NULL
in	NULL
liver	NULL
hematopoiesis	NULL
,	NULL
resulting	NULL
in	NULL
severe	NULL
anemia	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
precursors	NULL
cells	NULL
present	NULL
in	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
animals	NULL
are	NULL
able	NULL
to	NULL
differentiate	NULL
in	NULL
culture	NULL
to	NULL
their	NULL
corresponding	NULL
mature	NULL
phenotypes	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
defect	NULL
is	NULL
in	NULL
the	NULL
failure	NULL
of	NULL
the	NULL
precursor	NULL
population	NULL
in	NULL
the	NULL
liver	NULL
to	NULL
expand	NULL
,	NULL
instead	NULL
of	NULL
in	NULL
the	NULL
differentiation	NULL
process	NULL
per	NULL
se	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

c-Myb	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
required	NULL
for	NULL
hematopoietic	NULL
cells	NULL
to	NULL
enter	NULL
S	NULL
phase	NULL
,	NULL
suggesting	NULL
that	NULL
c-Myb	NULL
is	NULL
important	NULL
for	NULL
efficient	NULL
cell	NULL
division	NULL
(	NULL
Stern	NULL
and	NULL
Smith	NULL
,	NULL
1986	NULL
;	NULL
Gewirtz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
recent	NULL
evidence	NULL
has	NULL
demonstrated	NULL
that	NULL
inactivation	NULL
of	NULL
c-Myb	NULL
in	NULL
hematopoietic	NULL
cells	NULL
triggers	NULL
apoptosis	NULL
and	NULL
that	NULL
c-Myb	NULL
regulates	NULL
expression	NULL
of	NULL
be/-2	NULL
,	NULL
which	NULL
protects	NULL
against	NULL
apoptosis	NULL
(	NULL
Frampton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Taylor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
one	NULL
result	NULL
of	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
c-myb	NULL
gene	NULL
is	NULL
the	NULL
loss	NULL
of	NULL
(	NULL
4	NULL
integrin	NULL
expression	NULL
.	NULL

As	NULL
outlined	NULL
above	NULL
,	NULL
the	NULL
failure	NULL
of	NULL
hematopoiesis	NULL
in	NULL
the	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
appears	NULL
to	NULL
result	NULL
from	NULL
a	NULL
failure	NULL
in	NULL
proliferation	NULL
and/	NULL
or	NULL
triggering	NULL
of	NULL
apoptosis	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Frampton	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Taylor	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
G4	NULL
integrin	NULL
can	NULL
transmit	NULL
signals	NULL
that	NULL
trigger	NULL
cell	NULL
proliferation	NULL
(	NULL
Nojima	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Damle	NULL
and	NULL
Aruffo	NULL
,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
adhesion	NULL
of	NULL
integrins	NULL
to	NULL
ligand	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
prevent	NULL
apoptosis	NULL
3929	NULL
A.A.Postigo	NULL
et	NULL
al	NULL
.	NULL

A	NULL
04	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
-76	NULL
[	NULL
ash	NULL
dic	NULL
}	NULL
sic	NULL
}	NULL
|	NULL
@	NULL
ss	NULL
!	NULL

|	NULL
{	NULL
mpste	NULL
}	NULL
[	NULL
EEpac	NULL
)	NULL
Gost	NULL
30	NULL
%	NULL
chloramphenicol	NULL
acetylated	NULL
Ha	NULL
tn	NULL
tnt	NULL
t	NULL
c	NULL
5a	NULL
%	NULL
a	NULL
,	NULL
'	NULL
o	NULL
*	NULL
0.47	NULL
3	NULL
``	NULL
*	NULL
%	NULL
``	NULL
Q	NULL
’	NULL
fcv	NULL
?	NULL

»	NULL
x	NULL
bas	NULL
C	NULL
,	NULL
B	NULL
04	NULL
(	NULL
+	NULL
)	NULL
hematopoietic	NULL
cells	NULL
sz	NULL
30	NULL
57	NULL
a	NULL
.	NULL

8	NULL
$	NULL
p	NULL
``	NULL
G	NULL
#	NULL
'	NULL
co	NULL
&	NULL
&	NULL
,	NULL
<	NULL
6	NULL
,	NULL
<	NULL
,	NULL
``	NULL
4	NULL
,	NULL
*C	NULL
,	NULL
ts	NULL
ol	NULL
oo	NULL
5	NULL
o	NULL
&	NULL
BD	NULL
3B	NULL
o	NULL
*	NULL
,	NULL
``	NULL
*	NULL
.	NULL

**	NULL
a/	NULL
b	NULL
,	NULL
to	NULL
``	NULL
*o	NULL
*	NULL
G.	NULL
h	NULL
Co	NULL
``	NULL
D	NULL
&	NULL
*	NULL
T2	NULL
z	NULL
'	NULL
C	NULL
.	NULL
'	NULL

o	NULL
<	NULL
T	NULL
'	NULL
c	NULL
,	NULL
'	NULL
>	NULL
(	NULL
Koopman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
loss	NULL
of	NULL
o4	NULL
integrin	NULL
in	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
failure	NULL
of	NULL
the	NULL
hematopoietic	NULL
population	NULL
to	NULL
expand	NULL
,	NULL
a	NULL
phenotype	NULL
observed	NULL
in	NULL
these	NULL
animals	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Early	NULL
during	NULL
hematopoiesis	NULL
,	NULL
G4	NULL
integrin	NULL
is	NULL
expressed	NULL
in	NULL
all	NULL
cell	NULL
lineages	NULL
:	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
precursors	NULL
,	NULL
erythroblasts	NULL
and	NULL
megakaryocytes	NULL
(	NULL
Miyake	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Rosemblat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Teixido	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Avraham	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sadahira	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Hamumura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

As	NULL
these	NULL
precursors	NULL
mature	NULL
,	NULL
G4	NULL
expression	NULL
becomes	NULL
restricted	NULL
to	NULL
lymphocytes	NULL
and	NULL
some	NULL
myeloid	NULL
cells	NULL
(	NULL
Lobb	NULL
and	NULL
Hemler	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
control	NULL
of	NULL
0A	NULL
expression	NULL
is	NULL
very	NULL
tightly	NULL
regulated	NULL
during	NULL
hematopoiesis	NULL
.	NULL

Regulation	NULL
of	NULL
4	NULL
integrin	NULL
expression	NULL
continues	NULL
to	NULL
be	NULL
critical	NULL
beyond	NULL
hematopoiesis	NULL
,	NULL
where	NULL
it	NULL
is	NULL
expressed	NULL
differentially	NULL
on	NULL
the	NULL
different	NULL
lymphocyte	NULL
subsets	NULL
(	NULL
Shimizu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Picker	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
up-regulated	NULL
upon	NULL
mitogenic	NULL
stimulation	NULL
(	NULL
Sanchez-Madrid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Deregulation	NULL
of	NULL
G4	NULL
expression	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
inflammatory	NULL
diseases	NULL
and	NULL
hematologic	NULL
malignancies	NULL
(	NULL
Freedman	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Moller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Juneja	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kuriyama	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

We	NULL
propose	NULL
that	NULL
control	NULL
of	NULL
4	NULL
integrin	NULL
expression	NULL
in	NULL
hematopoietic	NULL
cells	NULL
is	NULL
the	NULL
result	NULL
of	NULL
a	NULL
fine	NULL
balance	NULL
between	NULL
repression	NULL
by	NULL
ZEB	NULL
and	NULL
activation	NULL
by	NULL
c-Myb/Ets	NULL
.	NULL

ZEB	NULL
imposes	NULL
a	NULL
requirement	NULL
for	NULL
both	NULL
c-Myb	NULL
and	NULL
Ets	NULL
to	NULL
activate	NULL
the	NULL
4	NULL
gene	NULL
(	NULL
and	NULL
perhaps	NULL
other	NULL
3930	NULL
%	NULL
chloramphenicol	NULL
acetylated	NULL
F	NULL
Fig	NULL
.	NULL

6.	NULL
c-Myb	NULL
regulates	NULL
G4	NULL
gene	NULL
promoter	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Overexpression	NULL
of	NULL
c-Myb	NULL
in	NULL
the	NULL
04	NULL
(	NULL
-	NULL
)	NULL
HT1080	NULL
cell	NULL
line	NULL
overcomes	NULL
repression	NULL
by	NULL
ZEB	NULL
.	NULL

Three	NULL
ug	NULL
of	NULL
the	NULL
-7604CAT	NULL
,	NULL
-2.004CAT	NULL
,	NULL
pETS-ZEB-CAT	NULL
and	NULL
pETS-ZEB-MYB-CAT	NULL
reporter	NULL
constructs	NULL
were	NULL
co-transfected	NULL
with	NULL
0.9	NULL
ug	NULL
of	NULL
a	NULL
PSV-c-Myb	NULL
expression	NULL
vector	NULL
.	NULL

pETS-ZEB-CAT	NULL
indicates	NULL
that	NULL
the	NULL
ZEB	NULL
site	NULL
E361	NULL
was	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
-760A4CAT	NULL
reporter	NULL
.	NULL

pETS-ZEB-MYB-CAT	NULL
indicates	NULL
that	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
c-Myb	NULL
site	NULL
at	NULL
-134	NULL
bp	NULL
were	NULL
cloned	NULL
upstream	NULL
of	NULL
the	NULL
ZEB	NULL
sites	NULL
of	NULL
the	NULL
pETS-ZEB-CAT	NULL
construct	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
activity	NULL
of	NULL
the	NULL
04	NULL
gene	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
depends	NULL
on	NULL
synergistic	NULL
activity	NULL
of	NULL
c-Myb	NULL
and	NULL
Ets	NULL
transcription	NULL
factors	NULL
.	NULL

Mutation	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
(	NULL
indicated	NULL
by	NULL
pETSmut	NULL
)	NULL
abolishes	NULL
the	NULL
capacity	NULL
of	NULL
c-Myb	NULL
to	NULL
overcome	NULL
ZEB	NULL
repression	NULL
.	NULL

Thirty	NULL
ug	NULL
of	NULL
the	NULL
different	NULL
reporters	NULL
were	NULL
transfected	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
using	NULL
the	NULL
erythroleukemia	NULL
HEL	NULL
cell	NULL
line	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
ZEB	NULL
represses	NULL
transcriptional	NULL
activation	NULL
by	NULL
Ets	NULL
and	NULL
c-Myb	NULL
factors	NULL
individually	NULL
.	NULL

Three	NULL
ug	NULL
of	NULL
-76-G4-CAT	NULL
(	NULL
containing	NULL
five	NULL
copies	NULL
of	NULL
the	NULL
Gal4	NULL
DNA-binding	NULL
site	NULL
upstream	NULL
of	NULL
the	NULL
-7604CAT	NULL
)	NULL
was	NULL
co-transfected	NULL
in	NULL
HT1O80	NULL
cells	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
G-ZEB	NULL
which	NULL
encodes	NULL
a	NULL
fusion	NULL
protein	NULL
of	NULL
ZEB	NULL
with	NULL
the	NULL
DBD	NULL
of	NULL
Gal4	NULL
.	NULL

One	NULL
ug	NULL
of	NULL
pL-G	NULL
(	NULL
containing	NULL
six	NULL
LexA-binding	NULL
sites	NULL
and	NULL
two	NULL
Gal4	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
E1B	NULL
TATA	NULL
box	NULL
)	NULL
was	NULL
co-transfected	NULL
in	NULL
HT1080	NULL
with	NULL
0.5	NULL
ug	NULL
of	NULL
a	NULL
Gal4-c-Myb	NULL
expression	NULL
vector	NULL
with	NULL
or	NULL
without	NULL
2	NULL
ug	NULL
of	NULL
L-ZEB	NULL
which	NULL
encodes	NULL
a	NULL
fusion	NULL
protein	NULL
between	NULL
the	NULL
DBD	NULL
of	NULL
LexA	NULL
and	NULL
ZEB	NULL
.	NULL

RELATIVE	NULL
CELL	NULL
NUMBER	NULL
r	NULL
~-	NULL
``	NULL
IA	NULL
“	NULL
,	NULL
T	NULL
T	NULL
rer	NULL
rory	NULL
--	NULL
-	NULL
T	NULL
10°	NULL
10	NULL
10°	NULL
10°	NULL
LOG	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
Fig	NULL
.	NULL

7.	NULL
c-Myb	NULL
stimulates	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
04	NULL
gene	NULL
in	NULL
04	NULL
(	NULL
-	NULL
)	NULL
cells	NULL
.	NULL

Flow	NULL
cytometric	NULL
analysis	NULL
showing	NULL
that	NULL
G4	NULL
appears	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
the	NULL
04	NULL
(	NULL
-	NULL
)	NULL
/c-myb	NULL
(	NULL
-	NULL
)	NULL
T98G	NULL
glioblastoma	NULL
cell	NULL
line	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
after	NULL
stable	NULL
expression	NULL
of	NULL
c-Myb	NULL
[	NULL
SV-myb-M-T98G	NULL
cell	NULL
line	NULL
(	NULL
Melotti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
]	NULL
(	NULL
solid	NULL
line	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
B1	NULL
integrin	NULL
showed	NULL
no	NULL
significant	NULL
change	NULL
in	NULL
expression	NULL
.	NULL

Likewise	NULL
,	NULL
no	NULL
change	NULL
was	NULL
seen	NULL
in	NULL
the	NULL
level	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
5	NULL
integrin	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
fluorescence	NULL
intensity	NULL
of	NULL
an	NULL
isotype-matched	NULL
negative	NULL
control	NULL
antibody	NULL
overlaid	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
(	NULL
4	NULL
integrin	NULL
in	NULL
T98G	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

hematopoietic	NULL
genes	NULL
)	NULL
.	NULL

We	NULL
present	NULL
evidence	NULL
that	NULL
regulation	NULL
of	NULL
04	NULL
expression	NULL
can	NULL
result	NULL
from	NULL
variations	NULL
of	NULL
c-Myb	NULL
expression	NULL
:	NULL
c-Myb	NULL
levels	NULL
(	NULL
in	NULL
parallel	NULL
to	NULL
oA	NULL
expression	NULL
)	NULL
decline	NULL
during	NULL
hematopoiesis	NULL
as	NULL
precursors	NULL
mature	NULL
(	NULL
Graf	NULL
,	NULL
1992	NULL
)	NULL
and	NULL
increases	NULL
as	NULL
a	NULL
result	NULL
of	NULL
mitogenic	NULL
activation	NULL
(	NULL
Torrelli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Pauza	NULL
,	NULL
1987	NULL
)	NULL
.	NULL

Erythroblasts	NULL
and	NULL
megakaryocytes	NULL
lose	NULL
04	NULL
expression	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
c-myb	NULL
)	NULL
Gap	NULL
Gm	NULL
.	NULL

1	NULL
@	NULL
Crs	NULL
)	NULL
t	NULL
&	NULL
%	NULL
chloramphenicol	NULL
acetylated	NULL
L	NULL
tn	NULL
L_________J	NULL
-2.0CA	NULL
a	NULL
!	NULL

c-myb	NULL
(	NULL
-/-	NULL
)	NULL
c-myb	NULL
(	NULL
+/+	NULL
)	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Inactivation	NULL
or	NULL
disruption	NULL
of	NULL
the	NULL
c-myb	NULL
gene	NULL
abolishes	NULL
expression	NULL
of	NULL
4	NULL
integrin	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Overexpression	NULL
of	NULL
a	NULL
dominant-negative	NULL
form	NULL
of	NULL
c-Myb	NULL
(	NULL
DN-myb	NULL
;	NULL
MT	NULL
)	NULL
blocked	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
4	NULL
gene	NULL
promoter	NULL
in	NULL
Q4	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
.	NULL

Twenty-five	NULL
ug	NULL
of	NULL
-7604CAT	NULL
and	NULL
-2.004CAT	NULL
reporter	NULL
constructs	NULL
were	NULL
co-transfected	NULL
in	NULL
(	NULL
4	NULL
(	NULL
+	NULL
)	NULL
Jurkat	NULL
cells	NULL
with	NULL
25	NULL
,	NULL
50	NULL
and	NULL
75	NULL
ug	NULL
of	NULL
DN-myb	NULL
.	NULL

Note	NULL
that	NULL
DN-myb	NULL
blocked	NULL
the	NULL
activity	NULL
of	NULL
-2.0	NULL
o4	NULL
CAT	NULL
(	NULL
contains	NULL
c-Myb	NULL
sites	NULL
)	NULL
but	NULL
not	NULL
of	NULL
-760A4CAT	NULL
(	NULL
lacks	NULL
c-Myb	NULL
sites	NULL
)	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
(	NULL
4	NULL
is	NULL
expressed	NULL
on	NULL
all	NULL
hematopoietic	NULL
cells	NULL
in	NULL
E14.5	NULL
liver	NULL
of	NULL
c-myb	NULL
(	NULL
+/+	NULL
)	NULL
mice	NULL
(	NULL
B	NULL
)	NULL
but	NULL
was	NULL
not	NULL
evident	NULL
on	NULL
hematopoietic	NULL
cells	NULL
in	NULL
the	NULL
E14.5	NULL
liver	NULL
of	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
(	NULL
C	NULL
)	NULL
.	NULL

Frozen	NULL
sections	NULL
of	NULL
E14.5	NULL
mice	NULL
were	NULL
immunostained	NULL
with	NULL
anti-o4	NULL
antibody	NULL
as	NULL
described	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Precursors	NULL
in	NULL
the	NULL
fetal	NULL
liver	NULL
of	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
embryos	NULL
expressed	NULL
other	NULL
hematopoietic	NULL
markers	NULL
(	NULL
results	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

disappearance	NULL
of	NULL
c-Myb	NULL
as	NULL
they	NULL
mature	NULL
to	NULL
erythrocytes	NULL
and	NULL
platelets	NULL
(	NULL
Rosemblat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Avraham	NULL
et	NULL
al	NULL
.	NULL

1993	NULL
;	NULL
Sadahira	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Hamumura	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Lymphoid	NULL
and	NULL
some	NULL
subsets	NULL
of	NULL
myeloid	NULL
cells	NULL
also	NULL
down-regulate	NULL
(	NULL
4	NULL
expression	NULL
as	NULL
c-Myb	NULL
decreases	NULL
during	NULL
their	NULL
differentiation	NULL
,	NULL
although	NULL
they	NULL
still	NULL
express	NULL
04	NULL
when	NULL
they	NULL
reach	NULL
the	NULL
bloodstream	NULL
(	NULL
Lobb	NULL
and	NULL
Hemler	NULL
,	NULL
1994	NULL
)	NULL
.	NULL

Expression	NULL
is	NULL
again	NULL
up-regulated	NULL
upon	NULL
cellular	NULL
activation	NULL
(	NULL
Sanchez-Madrid	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
comprises	NULL
an	NULL
increasing	NULL
number	NULL
of	NULL
members	NULL
(	NULL
Leiden	NULL
,	NULL
1993	NULL
;	NULL
Wasylick	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Crepieux	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
set	NULL
of	NULL
Ets	NULL
factors	NULL
that	NULL
bind	NULL
the	NULL
04	NULL
promoter	NULL
seems	NULL
to	NULL
vary	NULL
from	NULL
one	NULL
cell	NULL
type	NULL
to	NULL
another	NULL
and	NULL
,	NULL
at	NULL
least	NULL
,	NULL
includes	NULL
Ets-1	NULL
and	NULL
GABP	NULL
a	NULL
and	NULL
[	NULL
}	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
and	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
and	NULL
activity	NULL
of	NULL
Ets	NULL
proteins	NULL
are	NULL
regulated	NULL
during	NULL
T	NULL
lymphocyte	NULL
differentiation	NULL
and	NULL
activation	NULL
(	NULL
Pognonec	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
;	NULL
Bhat	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
,	NULL
1990	NULL
;	NULL
Muthusamy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
Ets	NULL
sites	NULL
in	NULL
the	NULL
4	NULL
gene	NULL
promoter	NULL
are	NULL
active	NULL
c-Myb/Ets	NULL
overcome	NULL
ZEB	NULL
repression	NULL
in	NULL
most	NULL
cells	NULL
that	NULL
we	NULL
have	NULL
tested	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
,	NULL
like	NULL
those	NULL
of	NULL
c-Myb	NULL
,	NULL
their	NULL
activity	NULL
varies	NULL
during	NULL
hematopoietic	NULL
differentiation	NULL
and	NULL
in	NULL
different	NULL
hematopoietic	NULL
lineages	NULL
,	NULL
providing	NULL
an	NULL
additional	NULL
level	NULL
of	NULL
regulation	NULL
.	NULL

Likewise	NULL
,	NULL
it	NULL
is	NULL
also	NULL
possible	NULL
that	NULL
the	NULL
level	NULL
of	NULL
ZEB	NULL
in	NULL
hematopoietic	NULL
cells	NULL
changes	NULL
during	NULL
hematopoiesis	NULL
and/or	NULL
cell	NULL
activation	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
c-Myb	NULL
,	NULL
regulation	NULL
of	NULL
Ets	NULL
and/or	NULL
ZEB	NULL
activities	NULL
could	NULL
add	NULL
further	NULL
flexibility	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
oA	NULL
gene	NULL
(	NULL
and	NULL
perhaps	NULL
other	NULL
hematopoietic	NULL
genes	NULL
regulated	NULL
by	NULL
c-Myb/Ets	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
studies	NULL
presented	NULL
here	NULL
have	NULL
relied	NULL
on	NULL
the	NULL
comparison	NULL
of	NULL
promoter	NULL
activities	NULL
in	NULL
hematopoietic	NULL
cells	NULL
versus	NULL
non-hematopoietic	NULL
cells	NULL
,	NULL
they	NULL
provide	NULL
strong	NULL
evidence	NULL
that	NULL
c-Myb	NULL
and	NULL
Ets	NULL
factors	NULL
synergize	NULL
to	NULL
overcome	NULL
repression	NULL
by	NULL
ZEB	NULL
.	NULL

While	NULL
these	NULL
experiments	NULL
do	NULL
not	NULL
provide	NULL
conclusive	NULL
evidence	NULL
that	NULL
the	NULL
c-Myb/Ets-ZEB	NULL
regulatory	NULL
pathway	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
hematopoietic	NULL
cell	NULL
differentiation	NULL
and	NULL
function	NULL
,	NULL
taken	NULL
together	NULL
with	NULL
patterns	NULL
of	NULL
c-Myb	NULL
and	NULL
Ets	NULL
expression	NULL
and	NULL
the	NULL
experiments	NULL
in	NULL
the	NULL
c-myb	NULL
(	NULL
-/-	NULL
)	NULL
mice	NULL
,	NULL
these	NULL
experiments	NULL
suggest	NULL
that	NULL
this	NULL
balance	NULL
between	NULL
repression	NULL
by	NULL
ZEB	NULL
and	NULL
activation	NULL
by	NULL
c-Myb/Ets	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
4	NULL
gene	NULL
and	NULL
possibly	NULL
several	NULL
other	NULL
hematopoietic	NULL
genes	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
c-Myb	NULL
and	NULL
Ets	NULL
did	NULL
not	NULL
increase	NULL
transcription	NULL
significantly	NULL
above	NULL
the	NULL
level	NULL
with	NULL
Ets	NULL
alone	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
c-Myb/Ets	NULL
combination	NULL
does	NULL
not	NULL
overcome	NULL
repression	NULL
by	NULL
ZEB	NULL
simply	NULL
by	NULL
increasing	NULL
transcription	NULL
but	NULL
,	NULL
instead	NULL
,	NULL
the	NULL
c-Myb/Ets	NULL
synergy	NULL
activates	NULL
transcription	NULL
through	NULL
a	NULL
mechanism	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
either	NULL
factor	NULL
alone	NULL
.	NULL

It	NULL
will	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
resistance	NULL
to	NULL
ZEB	NULL
repression	NULL
.	NULL

However	NULL
,	NULL
further	NULL
information	NULL
about	NULL
how	NULL
c-Myb/Ets	NULL
synergize	NULL
to	NULL
activate	NULL
transcription	NULL
is	NULL
needed	NULL
.	NULL

ZEB	NULL
may	NULL
provide	NULL
a	NULL
tool	NULL
to	NULL
analyze	NULL
such	NULL
mechanisms	NULL
of	NULL
transcriptional	NULL
synergy	NULL
.	NULL

A	NULL
target	NULL
of	NULL
future	NULL
studies	NULL
will	NULL
be	NULL
the	NULL
components	NULL
of	NULL
the	NULL
basal	NULL
transcription	NULL
complex	NULL
that	NULL
interact	NULL
with	NULL
c-Myb/Ets	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
the	NULL
combination	NULL
of	NULL
c-Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
interact	NULL
with	NULL
basal	NULL
transcription	NULL
complex	NULL
components	NULL
in	NULL
a	NULL
fashion	NULL
distinct	NULL
from	NULL
either	NULL
factor	NULL
alone	NULL
and	NULL
in	NULL
a	NULL
manner	NULL
that	NULL
is	NULL
resistant	NULL
to	NULL
disruption	NULL
by	NULL
ZEB	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
culture	NULL
The	NULL
HT1O80	NULL
fibrosarcoma	NULL
[	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
]	NULL
and	NULL
C33A	NULL
cervical	NULL
carcinoma	NULL
cell	NULL
lines	NULL
(	NULL
ATCC	NULL
)	NULL
were	NULL
mantained	NULL
in	NULL
Dulbecco	NULL
's	NULL
modified	NULL
Eagle	NULL
's	NULL
medium	NULL
(	NULL
DMEM	NULL
)	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
and	NULL
5	NULL
%	NULL
calf	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

The	NULL
T-cell	NULL
line	NULL
Jurkat	NULL
(	NULL
ATCC	NULL
)	NULL
,	NULL
B-cell	NULL
line	NULL
Raji	NULL
(	NULL
ATCC	NULL
)	NULL
and	NULL
the	NULL
erythroleukemia	NULL
HEL	NULL
cell	NULL
line	NULL
(	NULL
ATCC	NULL
)	NULL
were	NULL
mantained	NULL
in	NULL
RPMI	NULL
1640	NULL
media	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
.	NULL

C2C12	NULL
myoblasts	NULL
(	NULL
ATCC	NULL
)	NULL
and	NULL
C3H10T1/2	NULL
fibroblasts	NULL
(	NULL
ATCC	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
DMEM	NULL
containing	NULL
13	NULL
%	NULL
FCS	NULL
.	NULL

For	NULL
differentiation	NULL
of	NULL
C2C12	NULL
myoblasts	NULL
to	NULL
myotubes	NULL
,	NULL
cells	NULL
were	NULL
changed	NULL
to	NULL
DMEM-2	NULL
%	NULL
horse	NULL
serum	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
as	NULL
described	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
and	NULL
maintained	NULL
for	NULL
4	NULL
days	NULL
;	NULL
by	NULL
this	NULL
time	NULL
>	NULL
90	NULL
%	NULL
of	NULL
cells	NULL
had	NULL
fused	NULL
into	NULL
myotubes	NULL
.	NULL

The	NULL
glioblastoma	NULL
cell	NULL
line	NULL
T98G	NULL
and	NULL
its	NULL
c-myb	NULL
overexpression	NULL
derivative	NULL
SV-myb-T98G	NULL
were	NULL
obtained	NULL
from	NULL
B.Calabretta	NULL
(	NULL
Jefferson	NULL
University	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
)	NULL
(	NULL
Melotti	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
and	NULL
mantained	NULL
in	NULL
the	NULL
same	NULL
media	NULL
as	NULL
the	NULL
HT1O80	NULL
cell	NULL
line	NULL
.	NULL

Plasmid	NULL
construction	NULL
04	NULL
promoter	NULL
deletion	NULL
constructs	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Numbers	NULL
in	NULL
the	NULL
construct	NULL
name	NULL
indicate	NULL
the	NULL
amount	NULL
of	NULL
5'-flanking	NULL
sequence	NULL
present	NULL
.	NULL

PSV-CAT	NULL
has	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
;	NULL
Weintraub	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Fragments	NULL
of	NULL
the	NULL
o4	NULL
gene	NULL
promoter	NULL
were	NULL
obtained	NULL
by	NULL
PCR	NULL
with	NULL
primers	NULL
containing	NULL
KpnI	NULL
(	NULL
5	NULL
'	NULL
)	NULL
and	NULL
Apal	NULL
(	NULL
3	NULL
'	NULL
)	NULL
sites	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

The	NULL
products	NULL
were	NULL
digested	NULL
with	NULL
3931	NULL
A.A.Postigo	NULL
et	NULL
al	NULL
.	NULL

Kpni-Apal	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
corresponding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
in	NULL
-76CAT	NULL
(	NULL
Rosen	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

For	NULL
E	NULL
box	NULL
constructs	NULL
,	NULL
annealed	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
indicated	NULL
E	NULL
box	NULL
(	NULL
es	NULL
)	NULL
along	NULL
with	NULL
either	NULL
3	NULL
or	NULL
10	NULL
bp	NULL
of	NULL
flanking	NULL
sequence	NULL
(	NULL
results	NULL
were	NULL
identical	NULL
with	NULL
both	NULL
)	NULL
and	NULL
containing	NULL
KpnI	NULL
and	NULL
Apal	NULL
sites	NULL
were	NULL
cloned	NULL
into	NULL
the	NULL
corresponding	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
Ets	NULL
sites	NULL
in	NULL
-76CAT	NULL
.	NULL

In	NULL
E361M	NULL
,	NULL
the	NULL
CACCTG	NULL
core	NULL
was	NULL
mutated	NULL
to	NULL
TTGGCC	NULL
or	NULL
TTCCCC	NULL
and	NULL
in	NULL
E399	NULL
to	NULL
ACGCCT	NULL
or	NULL
ACCCCA	NULL
,	NULL
which	NULL
blocked	NULL
nuclear	NULL
protein	NULL
binding	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Prokaryotic	NULL
expression	NULL
vector	NULL
for	NULL
human	NULL
c-myb	NULL
Flag	NULL
(	NULL
Flag-c-omyb	NULL
)	NULL
and	NULL
eukaryotic	NULL
expression	NULL
vectors	NULL
pSV	NULL
and	NULL
pSV-c-myb	NULL
were	NULL
obtained	NULL
from	NULL
B.Calabretta	NULL
.	NULL

Expression	NULL
vectors	NULL
for	NULL
E12	NULL
and	NULL
E47	NULL
bHLH	NULL
E	NULL
proteins	NULL
were	NULL
obtained	NULL
from	NULL
FPeverali	NULL
(	NULL
EMBL	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
for	NULL
ZEB	NULL
was	NULL
constructed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
Postigo	NULL
and	NULL
Dean	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
dominant-negative	NULL
c-Myb	NULL
MT	NULL
construct	NULL
was	NULL
obtained	NULL
from	NULL
K.Weston	NULL
(	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Gal4-c-Myb	NULL
CD	NULL
was	NULL
obtained	NULL
from	NULL
J.S.Lipsick	NULL
(	NULL
State	NULL
University	NULL
of	NULL
New	NULL
York	NULL
,	NULL
Stony	NULL
Brook	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

pG-L	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
Weintraub	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Full-length	NULL
ZEB	NULL
cDNA	NULL
was	NULL
fused	NULL
in-frame	NULL
with	NULL
the	NULL
the	NULL
DBDs	NULL
of	NULL
Gal4	NULL
and	NULL
LexA	NULL
proteins	NULL
by	NULL
cloning	NULL
in	NULL
BamHI-Xbal	NULL
sites	NULL
of	NULL
PM1	NULL
and	NULL
pBXL3	NULL
(	NULL
Weintraub	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
to	NULL
make	NULL
Gal4-ZEB	NULL
(	NULL
G-ZEB	NULL
)	NULL
and	NULL
LexA-ZEB	NULL
(	NULL
L-ZEB	NULL
)	NULL
fusion	NULL
proteins	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
pETS-ZEB-MYB-CAT	NULL
reporter	NULL
construct	NULL
containing	NULL
Ets	NULL
sites	NULL
,	NULL
ZEB	NULL
sites	NULL
and	NULL
c-Myb	NULL
sites	NULL
was	NULL
constructed	NULL
in	NULL
the	NULL
following	NULL
way	NULL
:	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
E361	NULL
site	NULL
in	NULL
(	NULL
4	NULL
integrin	NULL
(	NULL
including	NULL
6	NULL
bp	NULL
upstream	NULL
and	NULL
downstream	NULL
of	NULL
the	NULL
E	NULL
box	NULL
consensus	NULL
site	NULL
)	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
KpnlI-Apal	NULL
sites	NULL
of	NULL
7604CAT	NULL
(	NULL
pETS-CAT	NULL
)	NULL
to	NULL
make	NULL
pETS-ZEB-CAT	NULL
.	NULL

Then	NULL
,	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
c-Myb	NULL
site	NULL
at	NULL
-134	NULL
bp	NULL
in	NULL
the	NULL
04	NULL
gene	NULL
(	NULL
other	NULL
c-Myb	NULL
sites	NULL
from	NULL
the	NULL
04	NULL
promoter	NULL
were	NULL
also	NULL
used	NULL
with	NULL
identical	NULL
results	NULL
)	NULL
were	NULL
cloned	NULL
in	NULL
Clal-Stul	NULL
sites	NULL
of	NULL
a	NULL
polylinker	NULL
blunt	NULL
ended	NULL
and	NULL
cloned	NULL
at	NULL
the	NULL
KpnI	NULL
site	NULL
to	NULL
make	NULL
pETS-ZEB-MYB-CAT	NULL
.	NULL

pETS-MYB-CAT	NULL
was	NULL
constructed	NULL
in	NULL
a	NULL
similar	NULL
way	NULL
but	NULL
lacking	NULL
the	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
E361	NULL
site	NULL
.	NULL

Transient	NULL
transfections	NULL
and	NULL
CAT	NULL
assays	NULL
Jurkat	NULL
,	NULL
HEL	NULL
and	NULL
Raji	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
electroporation	NULL
,	NULL
and	NULL
other	NULL
cells	NULL
were	NULL
transfected	NULL
by	NULL
the	NULL
calcium	NULL
phosphate	NULL
method	NULL
(	NULL
Rosen	NULL
et	NULL
aZ	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
,	NULL
lysates	NULL
were	NULL
collected	NULL
,	NULL
the	NULL
transfection	NULL
efficiency	NULL
was	NULL
corrected	NULL
and	NULL
CAT	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
brought	NULL
to	NULL
a	NULL
total	NULL
of	NULL
6	NULL
jug	NULL
for	NULL
60	NULL
mm	NULL
(	NULL
or	NULL
20	NULL
ug	NULL
for	NULL
100	NULL
mm	NULL
)	NULL
dishes	NULL
.	NULL

For	NULL
transfection	NULL
in	NULL
C2C12	NULL
myotubes	NULL
,	NULL
myoblast	NULL
cells	NULL
were	NULL
switched	NULL
to	NULL
media	NULL
containing	NULL
2	NULL
%	NULL
horse	NULL
serum	NULL
and	NULL
cells	NULL
were	NULL
maintained	NULL
for	NULL
4	NULL
days	NULL
before	NULL
harvesting	NULL
for	NULL
analysis	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Gel	NULL
retardation	NULL
assays	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
Osborn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
.	NULL

Oligonucleotide	NULL
probes	NULL
were	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-°	NULL
``	NULL
P	NULL
]	NULL
JATP	NULL
using	NULL
T4	NULL
polynucleotide	NULL
kinase	NULL
.	NULL

The	NULL
EcoRI	NULL
ends	NULL
of	NULL
the	NULL
-130/400	NULL
04	NULL
fragment	NULL
were	NULL
labeled	NULL
with	NULL
Klenow	NULL
fragment	NULL
and	NULL
[	NULL
&	NULL
-°P	NULL
]	NULL
dATP	NULL
.	NULL

Two	NULL
to	NULL
three	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
extracts	NULL
or	NULL
0.1	NULL
pill	NULL
of	NULL
bacterial	NULL
extracts	NULL
from	NULL
GST-ZEB-transformed	NULL
bacteria	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
and	NULL
0.5	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dIdC	NULL
)	NULL
in	NULL
25	NULL
pil	NULL
of	NULL
reaction	NULL
mix	NULL
containing	NULL
10	NULL
mM	NULL
Tris-HCI	NULL
pH	NULL
7.9	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
a	NULL
50-fold	NULL
excess	NULL
of	NULL
unlabeled	NULL
probe	NULL
or	NULL
0.5	NULL
ug	NULL
of	NULL
antibodies	NULL
per	NULL
reaction	NULL
.	NULL

After	NULL
10	NULL
min	NULL
,	NULL
6	NULL
fmol	NULL
of	NULL
labeled	NULL
probe	NULL
was	NULL
added	NULL
for	NULL
10	NULL
min	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
,	NULL
followed	NULL
by	NULL
another	NULL
10	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Then	NULL
,	NULL
samples	NULL
were	NULL
subjected	NULL
to	NULL
electrophoresis	NULL
as	NULL
described	NULL
(	NULL
Rosen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

Antibodies	NULL
against	NULL
USF	NULL
,	NULL
myoD	NULL
,	NULL
HEB	NULL
,	NULL
E2	NULL
proteins	NULL
and	NULL
c-Myb	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnologies	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Antibody	NULL
against	NULL
ZEB	NULL
was	NULL
obtained	NULL
from	NULL
H.Kondoh	NULL
(	NULL
Osaka	NULL
University	NULL
,	NULL
Osaka	NULL
,	NULL
Japan	NULL
)	NULL
(	NULL
Funahashi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

FACS	NULL
analysis	NULL
Approximately	NULL
1X10°	NULL
cells	NULL
were	NULL
incubated	NULL
at	NULL
4°C	NULL
with	NULL
50	NULL
ul	NULL
of	NULL
hybridoma	NULL
culture	NULL
supernatant	NULL
of	NULL
TS2/16	NULL
(	NULL
B1	NULL
integrin	NULL
)	NULL
or	NULL
HP2/1	NULL
(	NULL
04	NULL
integrin	NULL
)	NULL
mAbs	NULL
(	NULL
FSanchez-Madrid	NULL
,	NULL
Hospital	NULL
de	NULL
la	NULL
Princesa	NULL
,	NULL
Spain	NULL
)	NULL
(	NULL
Pulido	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
or	NULL
50	NULL
ul	NULL
of	NULL
10	NULL
ug/ml	NULL
solutions	NULL
of	NULL
P1D6	NULL
mAb	NULL
(	NULL
«	NULL
5	NULL
integrin	NULL
,	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
or	NULL
control	NULL
mouse	NULL
IgG1	NULL
or	NULL
IgG2a	NULL
(	NULL
Sigma	NULL
Chem	NULL
.	NULL

Co	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
for	NULL
30	NULL
min	NULL
.	NULL

After	NULL
two	NULL
washes	NULL
with	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
goat	NULL
anti-mouse	NULL
Ig	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
'	NULL
;	NULL
fragment-fluorescein	NULL
isothiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
(	NULL
1:100	NULL
dilution	NULL
)	NULL
(	NULL
Dako	NULL
,	NULL
Glostrup	NULL
,	NULL
Denmark	NULL
)	NULL
for	NULL
another	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
,	NULL
and	NULL
green	NULL
fluorescence	NULL
was	NULL
examined	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
a	NULL
FACScan	NULL
.	NULL

Tissue	NULL
staining	NULL
Tissue	NULL
sections	NULL
from	NULL
e-myb	NULL
(	NULL
-/-	NULL
)	NULL
,	NULL
(	NULL
-/+	NULL
)	NULL
and	NULL
(	NULL
+/+	NULL
)	NULL
mice	NULL
(	NULL
Mucenski	NULL
,	NULL
1991	NULL
)	NULL
were	NULL
immunostained	NULL
with	NULL
anti-04	NULL
integrin	NULL
(	NULL
PS/2	NULL
,	NULL
Pharmingen	NULL
,	NULL
3932	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
TER	NULL
119	NULL
antigen	NULL
(	NULL
TER119	NULL
,	NULL
Pharmingen	NULL
)	NULL
and	NULL
CD45	NULL
(	NULL
I-3/2.3	NULL
,	NULL
M.Thomas	NULL
,	NULL
Washington	NULL
University	NULL
,	NULL
MO	NULL
)	NULL
and	NULL
examined	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
.	NULL

Cell	NULL
staining	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
Mucenski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
Acknowledgements	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
Drs	NULL
B.Calabretta	NULL
,	NULL
T.Kadesch	NULL
,	NULL
H.Kondoh	NULL
,	NULL
J	NULL
.	NULL

$	NULL
.Lipsick	NULL
,	NULL
F.Peverali	NULL
,	NULL
FSanchez-Madrid	NULL
,	NULL
M.	NULL
Thomas	NULL
,	NULL
H.	NULL
Weintraub	NULL
and	NULL
K.	NULL
Weston	NULL
for	NULL
antibodies	NULL
,	NULL
plasmids	NULL
and	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
T.Graf	NULL
,	NULL
C.Hernandez-Munain	NULL
and	NULL
R.Kopan	NULL
for	NULL
helpful	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
the	NULL
Leukemia	NULL
Society	NULL
of	NULL
America	NULL
.	NULL

References	NULL
Allen	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Forbush	NULL
,	NULL
K.A	NULL
.	NULL

and	NULL
Perlmutter	NULL
,	NULL
R.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Functional	NULL
dissection	NULL
of	NULL
the	NULL
Ick	NULL
proximal	NULL
promoter	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
2758-2768	NULL
.	NULL

Arroyo	NULL
,	NULL
A.G.	NULL
,	NULL
Yang	NULL
,	NULL
J.T	NULL
.	NULL

,	NULL
Raybum	NULL
,	NULL
H.	NULL
,	NULL
Hynes	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Differential	NULL
requirements	NULL
for	NULL
4	NULL
integrins	NULL
during	NULL
fetal	NULL
and	NULL
adult	NULL
hematopoiesis	NULL
.	NULL

Cell	NULL
,	NULL
85	NULL
,	NULL
997-1008	NULL
.	NULL

Avraham	NULL
,	NULL
H.	NULL
,	NULL
Cowley	NULL
,	NULL
S.	NULL
,	NULL
Chi	NULL
,	NULL
S.Y	NULL
.	NULL

,	NULL
Jiang	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Groopman	NULL
,	NULL
J.E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Characterization	NULL
of	NULL
adhesive	NULL
interactions	NULL
between	NULL
human	NULL
endothelial	NULL
cells	NULL
and	NULL
megakaryocytes	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
91	NULL
,	NULL
2378-2384	NULL
.	NULL

Badiani	NULL
,	NULL
P.	NULL
,	NULL
Corbella	NULL
,	NULL
P	NULL
,	NULL
Kioussis	NULL
,	NULL
D.	NULL
,	NULL
Marvel	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Weston	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Dominant	NULL
interfering	NULL
alleles	NULL
define	NULL
a	NULL
role	NULL
for	NULL
c-myb	NULL
in	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
8	NULL
,	NULL
770-782	NULL
.	NULL

Bhat	NULL
,	NULL
N.K	NULL
.	NULL

ef	NULL
al	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Expression	NULL
of	NULL
Ets	NULL
genes	NULL
in	NULL
mouse	NULL
thymocyte	NULL
subsets	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
142	NULL
,	NULL
672-678	NULL
.	NULL

Bhat	NULL
,	NULL
N.K	NULL
.	NULL

,	NULL
Thompson	NULL
,	NULL
C.B	NULL
.	NULL

,	NULL
Lindsten	NULL
,	NULL
T.	NULL
,	NULL
June	NULL
,	NULL
C.H	NULL
.	NULL

,	NULL
Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
Koizumi	NULL
,	NULL
S.	NULL
,	NULL
Fisher	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
Papas	NULL
,	NULL
T.S	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Reciprocal	NULL
expression	NULL
of	NULL
human	NULL
ETSI	NULL
and	NULL
ETS2	NULL
genes	NULL
during	NULL
T-cell	NULL
activation	NULL
:	NULL
regulatory	NULL
role	NULL
for	NULL
the	NULL
protooncogene	NULL
ETSI	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
3723-3727	NULL
.	NULL

Crepieux	NULL
,	NULL
P.	NULL
,	NULL
Coll	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Stehelin	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
Ets	NULL
family	NULL
of	NULL
proteins	NULL
:	NULL
weak	NULL
modulators	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
quest	NULL
for	NULL
transcriptional	NULL
partners	NULL
.	NULL

Crif	NULL
.	NULL

Rev	NULL
.	NULL

Oncogen	NULL
.	NULL

,	NULL
5	NULL
,	NULL
615-638	NULL
.	NULL

Damle	NULL
,	NULL
N.K	NULL
.	NULL

and	NULL
Aruffo	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
induces	NULL
T-cell	NULL
antigen	NULL
receptor-dependent	NULL
activation	NULL
of	NULL
CD4+T	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
6403-6407	NULL
.	NULL

Dorshkind	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Transcriptional	NULL
control	NULL
points	NULL
during	NULL
lymphopoiesis	NULL
.	NULL

Cell	NULL
,	NULL
79	NULL
,	NULL
885-892	NULL
.	NULL

Dudek	NULL
,	NULL
H.	NULL
,	NULL
Tantravahi	NULL
,	NULL
R.V	NULL
.	NULL

,	NULL
Rao	NULL
,	NULL
V.N	NULL
.	NULL

,	NULL
Reddy	NULL
,	NULL
E.S	NULL
.	NULL

and	NULL
Reddy	NULL
,	NULL
E.P	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
in	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
mim-1	NULL
promoter	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
1291-1295	NULL
.	NULL

Duncan	NULL
,	NULL
D.D	NULL
.	NULL

,	NULL
Adlam	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Siu	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Asymmetric	NULL
redundancy	NULL
in	NULL
CD4	NULL
silencer	NULL
function	NULL
.	NULL

Immunity	NULL
,	NULL
4	NULL
,	NULL
301-311	NULL
.	NULL

Fortini	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
Lai	NULL
,	NULL
Z.C	NULL
.	NULL

and	NULL
Rubin	NULL
,	NULL
G.M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
The	NULL
Drosophila	NULL
zfh-1	NULL
and	NULL
zfh-2	NULL
genes	NULL
encode	NULL
novel	NULL
proteins	NULL
containing	NULL
both	NULL
zinc-finger	NULL
and	NULL
homeodomain	NULL
motifs	NULL
.	NULL

Meck	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
34	NULL
,	NULL
113-122	NULL
.	NULL

Frampton	NULL
,	NULL
J.	NULL
,	NULL
Ramqvist	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
v-myb	NULL
of	NULL
E26	NULL
leukemia	NULL
virus	NULL
up-regulates	NULL
be/-2	NULL
and	NULL
suppresses	NULL
apoptosis	NULL
in	NULL
myeloid	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
2720-273	NULL
.	NULL

Freedman	NULL
,	NULL
A.S.	NULL
,	NULL
Munro	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Morimoto	NULL
,	NULL
C.	NULL
,	NULL
Mclntyre	NULL
,	NULL
B.M	NULL
.	NULL

,	NULL
Rhynhart	NULL
,	NULL
K.	NULL
,	NULL
Lee	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Nadler	NULL
,	NULL
L.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Follicular	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
cell	NULL
adhesion	NULL
to	NULL
normal	NULL
germinal	NULL
centers	NULL
and	NULL
neoplastic	NULL
follicles	NULL
involves	NULL
very	NULL
late	NULL
antigen-4	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

Blood	NULL
,	NULL
79	NULL
,	NULL
206-212	NULL
.	NULL

Funahashi	NULL
,	NULL
J.	NULL
,	NULL
Seikido	NULL
,	NULL
R.	NULL
,	NULL
Murai	NULL
,	NULL
K.	NULL
,	NULL
Kamachi	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Kondoh	NULL
,	NULL
H.	NULL
(	NULL
1993	NULL
)	NULL
Delta-crystallin	NULL
enhancer	NULL
binding	NULL
protein	NULL
delta	NULL
EF1	NULL
is	NULL
a	NULL
zinc	NULL
finger-homeodomain	NULL
protein	NULL
implicated	NULL
in	NULL
postgastrulation	NULL
embryogenesis	NULL
.	NULL

Development	NULL
,	NULL
119	NULL
,	NULL
433-446	NULL
.	NULL

Genetta	NULL
,	NULL
T.	NULL
,	NULL
Ruezinsky	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kadesch	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Displacement	NULL
of	NULL
an	NULL
E	NULL
box-binding	NULL
repressor	NULL
by	NULL
basic	NULL
helix-loop-helix	NULL
proteins	NULL
:	NULL
implications	NULL
for	NULL
B-cell	NULL
specificity	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
enhancer	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
6153-6163	NULL
.	NULL

Gewirtz	NULL
,	NULL
A.M.	NULL
,	NULL
Anfossi	NULL
,	NULL
G.	NULL
,	NULL
Venturelli	NULL
,	NULL
D.	NULL
,	NULL
Valpreda	NULL
,	NULL
S.	NULL
,	NULL
Sims	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
G1/S	NULL
transition	NULL
in	NULL
normal	NULL
human	NULL
T-lymphocytes	NULL
requires	NULL
the	NULL
nuclear	NULL
protein	NULL
encoded	NULL
by	NULL
c-myb	NULL
.	NULL

Science	NULL
,	NULL
245	NULL
,	NULL
180-183	NULL
.	NULL

Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Myb	NULL
:	NULL
a	NULL
transcriptional	NULL
activator	NULL
linking	NULL
proliferation	NULL
and	NULL
differentiation	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Curr	NULL
:	NULL
Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

,	NULL
2	NULL
,	NULL
249-255	NULL
.	NULL

Hamamura	NULL
,	NULL
K.	NULL
,	NULL
Matsuda	NULL
,	NULL
H.	NULL
,	NULL
Takeuchi	NULL
,	NULL
Y.	NULL
,	NULL
Habu	NULL
,	NULL
S.	NULL
,	NULL
Yagita	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Okumura	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
A	NULL
critical	NULL
role	NULL
of	NULL
VLA-4	NULL
in	NULL
erythropoiesis	NULL
in	NULL
vivo	NULL
.	NULL

Blood	NULL
,	NULL
$	NULL
7	NULL
,	NULL
2513-2517	NULL
.	NULL

Hernandez-Munain	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Krangel	NULL
,	NULL
M.S	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Regulation	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
delta	NULL
enhancer	NULL
by	NULL
functional	NULL
cooperation	NULL
between	NULL
c-Myb	NULL
and	NULL
core-binding	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
473-483	NULL
.	NULL

Hirsch	NULL
,	NULL
E.	NULL
,	NULL
Iglesias	NULL
,	NULL
A.	NULL
,	NULL
Potocnik	NULL
,	NULL
A.J	NULL
.	NULL

,	NULL
Hartmann	NULL
,	NULL
U	NULL
.	NULL

and	NULL
Fassler	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Impaired	NULL
migration	NULL
but	NULL
not	NULL
differentiation	NULL
of	NULL
haematopoietic	NULL
stem	NULL
cells	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
B1	NULL
integrins	NULL
.	NULL

Nature	NULL
,	NULL
380	NULL
,	NULL
171-175	NULL
.	NULL

Juneja	NULL
,	NULL
H.S	NULL
.	NULL

,	NULL
Schmalsteig	NULL
,	NULL
F.C	NULL
.	NULL

,	NULL
Lee	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Chen	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
and	NULL
VLA-4	NULL
are	NULL
obligatory	NULL
adhesion	NULL
proteins	NULL
in	NULL
the	NULL
heterotypic	NULL
adherence	NULL
between	NULL
human	NULL
leukemia/lymphoma	NULL
cells	NULL
and	NULL
marrow	NULL
stromal	NULL
cells	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

,	NULL
21	NULL
,	NULL
444-450	NULL
.	NULL

Koopman	NULL
,	NULL
G.	NULL
,	NULL
Keehnen	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Lindhout	NULL
,	NULL
E.	NULL
,	NULL
Newman	NULL
,	NULL
W.	NULL
,	NULL
Shimizu	NULL
,	NULL
Y.	NULL
,	NULL
van	NULL
Seventer	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
de	NULL
Groot	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Pals	NULL
,	NULL
S.T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Adhesion	NULL
through	NULL
the	NULL
LFA-1	NULL
(	NULL
CD11a/CD18	NULL
)	NULL
-ICAM-1	NULL
(	NULL
CD54	NULL
)	NULL
and	NULL
the	NULL
VLA-4	NULL
(	NULL
CD49d	NULL
)	NULL
-VCAM-1	NULL
(	NULL
CD106	NULL
)	NULL
pathways	NULL
prevents	NULL
apoptosis	NULL
of	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
152	NULL
,	NULL
3760-3767	NULL
.	NULL

Kuriyama	NULL
,	NULL
Y.	NULL
,	NULL
Nakano	NULL
,	NULL
.M	NULL
.	NULL

,	NULL
Kawanishi	NULL
,	NULL
Y.	NULL
,	NULL
Iwase,0	NULL
.	NULL

,	NULL
Kuge	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Toyama	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Significance	NULL
of	NULL
VLA-4	NULL
and	NULL
LFA-1	NULL
expressions	NULL
in	NULL
neoplastic	NULL
follicle	NULL
formation	NULL
and	NULL
its	NULL
deterioration	NULL
in	NULL
B-cell	NULL
non-Hodgkin	NULL
's	NULL
lymphomas	NULL
.	NULL

Leukemia	NULL
Lymph	NULL
.	NULL

,	NULL
13	NULL
,	NULL
123-129	NULL
.	NULL

Lai	NULL
,	NULL
Z.C	NULL
.	NULL

,	NULL
Rushton	NULL
,	NULL
E.	NULL
,	NULL
Bate.M	NULL
.	NULL

and	NULL
Rubin	NULL
,	NULL
G.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Loss	NULL
of	NULL
function	NULL
of	NULL
the	NULL
Drosophila	NULL
zfh-1	NULL
gene	NULL
results	NULL
in	NULL
abnormal	NULL
development	NULL
of	NULL
mesodermally	NULL
derived	NULL
tissues	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
4122-4126	NULL
.	NULL

Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Transcriptional	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
539-570	NULL
Lipsick	NULL
,	NULL
J.S	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
One	NULL
billion	NULL
years	NULL
of	NULL
Myb	NULL
.	NULL

Oncogene	NULL
,	NULL
13	NULL
,	NULL
223-235	NULL
.	NULL

Lobb	NULL
,	NULL
R.R	NULL
.	NULL

and	NULL
Hemler	NULL
,	NULL
M.E	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
The	NULL
pathophysiologic	NULL
role	NULL
of	NULL
(	NULL
4	NULL
integrins	NULL
in	NULL
vivo	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
94	NULL
,	NULL
1722-1728	NULL
.	NULL

McCracken	NULL
,	NULL
S.	NULL
,	NULL
Leung,8	NULL
.	NULL

,	NULL
Bosselut	NULL
,	NULL
R.	NULL
,	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Miyamoto	NULL
,	NULL
N.G	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Myb	NULL
and	NULL
Ets	NULL
related	NULL
transcription	NULL
factors	NULL
are	NULL
required	NULL
for	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
Ick	NULL
type	NULL
I	NULL
promoter	NULL
.	NULL

Oncogene	NULL
,	NULL
9	NULL
,	NULL
3609-9615	NULL
.	NULL

Melotti	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Ets-2	NULL
and	NULL
c-Myb	NULL
act	NULL
independently	NULL
in	NULL
regulating	NULL
expression	NULL
of	NULL
the	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
antigen	NULL
CD34	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
26	NULL
,	NULL
25303-25309	NULL
Melotti	NULL
,	NULL
P.	NULL
,	NULL
Ku	NULL
,	NULL
D.H	NULL
.	NULL

and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Regulation	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
hematopoietic	NULL
stem	NULL
cell	NULL
antigen	NULL
CD34	NULL
:	NULL
role	NULL
of	NULL
c-myb	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
179	NULL
,	NULL
1023-1028	NULL
.	NULL

Metz	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1991a	NULL
)	NULL
Fusion	NULL
of	NULL
the	NULL
nuclear	NULL
oncoproteins	NULL
v-Myb	NULL
and	NULL
v-Ets	NULL
is	NULL
required	NULL
for	NULL
the	NULL
leukemogenicity	NULL
of	NULL
E26	NULL
virus	NULL
.	NULL

Cell	NULL
,	NULL
66	NULL
,	NULL
95-105	NULL
.	NULL

Metz	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1991b	NULL
)	NULL
v-myb	NULL
and	NULL
v-ets	NULL
transform	NULL
chicken	NULL
erythroid	NULL
cells	NULL
and	NULL
cooperate	NULL
both	NULL
in	NULL
frans	NULL
and	NULL
in	NULL
cis	NULL
to	NULL
induce	NULL
distinct	NULL
differentiation	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
369-380	NULL
.	NULL

Miyake	NULL
,	NULL
K.	NULL
,	NULL
Weissman	NULL
,	NULL
LS	NULL
.	NULL

,	NULL
Greenberger	NULL
,	NULL
J.S	NULL
.	NULL

and	NULL
Kincade	NULL
,	NULL
P.W	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Evidence	NULL
for	NULL
a	NULL
role	NULL
of	NULL
the	NULL
integrin	NULL
VLA-4	NULL
in	NULL
lympho-hemopoiesis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
173	NULL
,	NULL
599-607	NULL
.	NULL

Moller	NULL
,	NULL
P.	NULL
,	NULL
Eichelmann	NULL
,	NULL
A.	NULL
,	NULL
Koretz	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Mechtersheimer	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Adhesion	NULL
molecules	NULL
VLA-1	NULL
to	NULL
VLA-6	NULL
define	NULL
discrete	NULL
stages	NULL
of	NULL
peripheral	NULL
B	NULL
lymphocyte	NULL
development	NULL
and	NULL
characterize	NULL
different	NULL
types	NULL
of	NULL
B	NULL
cell	NULL
neoplasia	NULL
.	NULL

Leukemia	NULL
,	NULL
6	NULL
,	NULL
256-264	NULL
.	NULL

Mucenski	NULL
,	NULL
ML	NULL
.	NULL

,	NULL
McLain	NULL
,	NULL
K.	NULL
,	NULL
Kier	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
Swerdlow	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
Schreiner	NULL
,	NULL
Miller	NULL
,	NULL
T.A	NULL
.	NULL

,	NULL
Pictryga	NULL
,	NULL
D.W.	NULL
,	NULL
Scott	NULL
,	NULL
and	NULL
Potter	NULL
,	NULL
S.S	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
A	NULL
functional	NULL
c-myb	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
murine	NULL
fetal	NULL
hepatic	NULL
hematopoiesis	NULL
.	NULL

Cell	NULL
,	NULL
65	NULL
,	NULL
677-689	NULL
.	NULL

Muthusamy	NULL
,	NULL
N.	NULL
,	NULL
Barton	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Leiden	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Defective	NULL
activation	NULL
and	NULL
survival	NULL
of	NULL
T	NULL
cells	NULL
lacking	NULL
the	NULL
Ets-1	NULL
transcription	NULL
factor	NULL
.	NULL

Nature	NULL
,	NULL
377	NULL
,	NULL
639-642	NULL
.	NULL

Ness	NULL
,	NULL
S.A.	NULL
,	NULL
Marknell	NULL
,	NULL
A.	NULL
and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
The	NULL
v-myb	NULL
oncogene	NULL
product	NULL
binds	NULL
to	NULL
and	NULL
activates	NULL
the	NULL
promyelocyte-specific	NULL
mim-1	NULL
gene	NULL
.	NULL

Cell	NULL
,	NULL
59	NULL
,	NULL
1115-1125	NULL
.	NULL

Nojima	NULL
,	NULL
Y.	NULL
,	NULL
Humphries	NULL
,	NULL
M.J	NULL
,	NULL
Mould	NULL
,	NULL
A.P	NULL
,	NULL
Komoriya	NULL
,	NULL
A.	NULL
,	NULL
Yamada	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Schlossman	NULL
,	NULL
S.F	NULL
.	NULL

and	NULL
Morimoto	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
VLA-4	NULL
mediate	NULL
CD3-dependent	NULL
CD4+	NULL
T	NULL
cell	NULL
activation	NULL
via	NULL
the	NULL
CS1	NULL
alternatively	NULL
spliced	NULL
domain	NULL
of	NULL
fibronectin	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
172	NULL
,	NULL
1185-1192	NULL
.	NULL

Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Hematopoiesis	NULL
:	NULL
how	NULL
does	NULL
it	NULL
happen	NULL
?	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
870-877	NULL
.	NULL

Osborn	NULL
,	NULL
L.	NULL
,	NULL
Kunkel	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
&	NULL
and	NULL
interleukin	NULL
1	NULL
stimulate	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
enhancer	NULL
by	NULL
activation	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
86	NULL
,	NULL
2336-2340	NULL
.	NULL

Pauza	NULL
,	NULL
C.D	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Regulation	NULL
of	NULL
human	NULL
T-lymphocyte	NULL
gene	NULL
expression	NULL
by	NULL
interleukin	NULL
2	NULL
:	NULL
immediate-response	NULL
genes	NULL
include	NULL
the	NULL
proto-oncogene	NULL
c-myb	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
7	NULL
,	NULL
342-348	NULL
.	NULL

Perrotti	NULL
,	NULL
D.	NULL
,	NULL
Melotti	NULL
,	NULL
P.	NULL
,	NULL
Skorski	NULL
,	NULL
T.	NULL
,	NULL
Casella	NULL
,	NULL
I.	NULL
,	NULL
Peschle	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Calabretta	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Overexpression	NULL
of	NULL
the	NULL
zinc	NULL
finger	NULL
protein	NULL
MZF1	NULL
inhibits	NULL
hematopoietic	NULL
development	NULL
from	NULL
embryonic	NULL
stem	NULL
cells	NULL
:	NULL
correlation	NULL
c-Myb/Ets	NULL
overcome	NULL
ZEB	NULL
repression	NULL
with	NULL
negative	NULL
regulation	NULL
of	NULL
CD34	NULL
and	NULL
c-myb	NULL
promoter	NULL
activity	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
15	NULL
,	NULL
6075-6087	NULL
.	NULL

Picker	NULL
,	NULL
L.J	NULL
.	NULL

,	NULL
Terstappen	NULL
,	NULL
L	NULL
.	NULL

W.	NULL
,	NULL
RottL.S	NULL
.	NULL

,	NULL
Streeter	NULL
,	NULL
PR	NULL
.	NULL

,	NULL
Stein	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Butcher	NULL
,	NULL
E.C	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Differential	NULL
expression	NULL
of	NULL
homing-associated	NULL
adhesion	NULL
molecules	NULL
by	NULL
T	NULL
cell	NULL
subsets	NULL
in	NULL
man	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
145	NULL
,	NULL
3247-3255	NULL
.	NULL

Pognonec	NULL
,	NULL
P.	NULL
,	NULL
Boulukos	NULL
,	NULL
K.E	NULL
,	NULL
Gesquiere	NULL
,	NULL
J.C.	NULL
,	NULL
Stehelin	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Ghysdael	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
results	NULL
in	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
c-ets-1	NULL
proteins	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
7	NULL
,	NULL
977-983	NULL
.	NULL

Postigo	NULL
,	NULL
A.A	NULL
.	NULL

and	NULL
Dean	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
ZEB	NULL
,	NULL
a	NULL
vertebrate	NULL
homolog	NULL
of	NULL
Drosophila	NULL
zfh-1	NULL
,	NULL
is	NULL
a	NULL
negative	NULL
regulator	NULL
of	NULL
muscle	NULL
differentiation	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
3935-3943	NULL
.	NULL

Pulido	NULL
,	NULL
R.	NULL
,	NULL
Elices	NULL
,	NULL
M.J.	NULL
,	NULL
Campanero	NULL
,	NULL
M.R	NULL
.	NULL

,	NULL
Osborn	NULL
,	NULL
L.	NULL
,	NULL
Schiffer	NULL
,	NULL
S.	NULL
,	NULL
Garcia-Pardo	NULL
,	NULL
A.	NULL
,	NULL
Lobb	NULL
,	NULL
R.	NULL
,	NULL
HemlerM.E	NULL
.	NULL

and	NULL
Sanchez-Madrid	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Functional	NULL
evidence	NULL
for	NULL
three	NULL
distinct	NULL
and	NULL
independently	NULL
inhibitable	NULL
adhesion	NULL
activities	NULL
mediated	NULL
by	NULL
the	NULL
human	NULL
integrin	NULL
VLA-4	NULL
.	NULL

Correlation	NULL
with	NULL
distinct	NULL
4	NULL
epitopes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
266	NULL
,	NULL
10241-10245	NULL
.	NULL

Radke	NULL
,	NULL
K.	NULL
,	NULL
Beug	NULL
,	NULL
H.	NULL
,	NULL
Kornfeld	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Graf	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Transformation	NULL
of	NULL
both	NULL
erythroid	NULL
and	NULL
myeloid	NULL
cells	NULL
by	NULL
E26	NULL
,	NULL
an	NULL
avian	NULL
leukemia	NULL
virus	NULL
that	NULL
contains	NULL
the	NULL
myb	NULL
gene	NULL
.	NULL

Cell	NULL
,	NULL
31	NULL
,	NULL
643-653	NULL
.	NULL

Roldan	NULL
,	NULL
E.	NULL
,	NULL
Garcia-Pardo	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Brieva	NULL
,	NULL
J.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
VLA-4-fibronectin	NULL
interaction	NULL
is	NULL
required	NULL
for	NULL
the	NULL
terminal	NULL
differentiation	NULL
of	NULL
human	NULL
bone	NULL
marrow	NULL
cells	NULL
capable	NULL
of	NULL
spontaneous	NULL
and	NULL
high	NULL
rate	NULL
immunoglobulin	NULL
secretion	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
,	NULL
1739-1747	NULL
.	NULL

Rosemblatt	NULL
,	NULL
M.	NULL
,	NULL
Vuillet-Gaugler	NULL
,	NULL
M.H	NULL
.	NULL

,	NULL
Leroy	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Coulombel	NULL
,	NULL
L	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Coexpression	NULL
of	NULL
two	NULL
fibronectin	NULL
receptors	NULL
,	NULL
VLA-4	NULL
and	NULL
VLA-5	NULL
,	NULL
by	NULL
immature	NULL
human	NULL
erythroblastic	NULL
precursor	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
87	NULL
,	NULL
6-11	NULL
.	NULL

Rosen	NULL
,	NULL
G.D.	NULL
,	NULL
Sanes	NULL
,	NULL
J.R.	NULL
,	NULL
LaChance	NULL
,	NULL
R.	NULL
,	NULL
Cunningham	NULL
,	NULL
J.M	NULL
.	NULL

,	NULL
Roman	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Dean	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Roles	NULL
for	NULL
the	NULL
integrin	NULL
VLA-4	NULL
and	NULL
its	NULL
counter	NULL
receptor	NULL
VCAM-1	NULL
in	NULL
myogenesis	NULL
.	NULL

Cell	NULL
,	NULL
69	NULL
,	NULL
1107-1119	NULL
.	NULL

Rosenm	NULL
,	NULL
G.D.	NULL
,	NULL
Barks	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Iademarco	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Fisher	NULL
,	NULL
R.J	NULL
.	NULL

and	NULL
Dean	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
An	NULL
intricate	NULL
arrangement	NULL
of	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
regulates	NULL
activity	NULL
of	NULL
the	NULL
alpha	NULL
4	NULL
integrin	NULL
gene	NULL
promoter	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
269	NULL
,	NULL
15652-15660	NULL
.	NULL

SadahiraY	NULL
.	NULL

,	NULL
Yoshino	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Monobe	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Very	NULL
late	NULL
activation	NULL
antigen	NULL
4-vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
interaction	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
erythroblastic	NULL
islands	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
181	NULL
,	NULL
411-415	NULL
.	NULL

Sanchez-Madrid	NULL
,	NULL
F	NULL
,	NULL
de	NULL
Landazuri	NULL
,	NULL
M.O	NULL
.	NULL

,	NULL
Morago	NULL
,	NULL
G.	NULL
,	NULL
Cebrian	NULL
,	NULL
M.	NULL
,	NULL
Acevedo	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Bernabeu	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
VLA-3	NULL
:	NULL
a	NULL
novel	NULL
polypeptide	NULL
association	NULL
within	NULL
the	NULL
VLA	NULL
molecular	NULL
complex	NULL
:	NULL
cell	NULL
distribution	NULL
and	NULL
biochemical	NULL
characterization	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
1343-1349	NULL
.	NULL

Sanchez	NULL
,	NULL
M.J.	NULL
,	NULL
-	NULL
Gutierrez-Ramos	NULL
,	NULL
J.C.	NULL
,	NULL
_	NULL
Fernandez	NULL
,	NULL
E.	NULL
,	NULL
-	NULL
Leonardo	NULL
,	NULL
E.	NULL
,	NULL
Lozano	NULL
,	NULL
J.	NULL
,	NULL
Martinez-A	NULL
.	NULL

,	NULL
C	NULL
.	NULL

and	NULL
Toribio	NULL
,	NULL
M.L	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Putative	NULL
prethymic	NULL
T	NULL
cell	NULL
precursors	NULL
within	NULL
the	NULL
early	NULL
human	NULL
embryonic	NULL
liver	NULL
:	NULL
a	NULL
molecular	NULL
and	NULL
functional	NULL
analysis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
177	NULL
,	NULL
19-33	NULL
.	NULL

Sawada,8	NULL
.	NULL

,	NULL
Scarborough	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Killeen	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Littman	NULL
,	NULL
D.R	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
A	NULL
lineage-specific	NULL
transcriptional	NULL
silencer	NULL
regulates	NULL
CD4	NULL
gene	NULL
expression	NULL
during	NULL
T	NULL
lymphocyte	NULL
development	NULL
.	NULL

Cell	NULL
,	NULL
77	NULL
,	NULL
917-929	NULL
.	NULL

Sawadogo	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Interaction	NULL
of	NULL
a	NULL
gene-specific	NULL
transcription	NULL
factor	NULL
with	NULL
the	NULL
adenovirus	NULL
major	NULL
late	NULL
promoter	NULL
upstream	NULL
of	NULL
the	NULL
TATA	NULL
box	NULL
region	NULL
.	NULL

Cell	NULL
,	NULL
43	NULL
,	NULL
165-175	NULL
.	NULL

Scott	NULL
,	NULL
E.W	NULL
.	NULL

,	NULL
Simon	NULL
,	NULL
M.C	NULL
.	NULL

,	NULL
Anastasi	NULL
,	NULL
)	NULL
.	NULL

and	NULL
Singh	NULL
,	NULL
J.H	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Requirement	NULL
of	NULL
transcriptional	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
development	NULL
of	NULL
multiple	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

Science	NULL
,	NULL
265	NULL
,	NULL
1573-1575	NULL
.	NULL

Shapiro	NULL
,	NULL
L.H	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Myb	NULL
and	NULL
Ets	NULL
proteins	NULL
cooperate	NULL
to	NULL
transactivate	NULL
an	NULL
early	NULL
myeloid	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
270	NULL
,	NULL
8763-8771	NULL
.	NULL

Sheppard	NULL
,	NULL
A.M.	NULL
,	NULL
Onken	NULL
,	NULL
M.D	NULL
.	NULL

,	NULL
Rosen	NULL
,	NULL
G.D.	NULL
,	NULL
Noakes	NULL
,	NULL
P.G	NULL
.	NULL

and	NULL
Dean	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Expanding	NULL
roles	NULL
for	NULL
alpha	NULL
4	NULL
integrin	NULL
and	NULL
its	NULL
ligands	NULL
in	NULL
development	NULL
.	NULL

Cell	NULL
Adkesion	NULL
Commun	NULL
.	NULL

,	NULL
2	NULL
,	NULL
27-43	NULL
.	NULL

Shimizu	NULL
,	NULL
Y.	NULL
,	NULL
Van	NULL
Seventer	NULL
,	NULL
G.A	NULL
.	NULL

,	NULL
Horgan	NULL
,	NULL
K.J	NULL
.	NULL

and	NULL
Shaw	NULL
,	NULL
S	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Regulated	NULL
expression	NULL
and	NULL
binding	NULL
of	NULL
three	NULL
VLA	NULL
(	NULL
beta	NULL
1	NULL
)	NULL
integrin	NULL
receptors	NULL
on	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
,	NULL
345	NULL
,	NULL
250-253	NULL
.	NULL

Shivdasani	NULL
,	NULL
R.A	NULL
.	NULL

and	NULL
Orkin	NULL
,	NULL
S.H	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
The	NULL
transcriptional	NULL
control	NULL
of	NULL
hematopoiesis	NULL
.	NULL

Blood	NULL
,	NULL
87	NULL
,	NULL
4025-4039	NULL
.	NULL

Siu	NULL
,	NULL
G.	NULL
,	NULL
Wurster	NULL
,	NULL
A.L	NULL
.	NULL

,	NULL
Lipsick	NULL
,	NULL
J.S	NULL
.	NULL

and	NULL
Hedrick	NULL
,	NULL
S.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Expression	NULL
of	NULL
the	NULL
CD4	NULL
gene	NULL
requires	NULL
a	NULL
myb	NULL
transcription	NULL
factor	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
1592-1604	NULL
.	NULL

Springer	NULL
,	NULL
T.A	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
,	NULL
76	NULL
,	NULL
301-314	NULL
.	NULL

Stern	NULL
,	NULL
J.B	NULL
.	NULL

and	NULL
Smith	NULL
,	NULL
K.A	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Interleukin-2	NULL
induction	NULL
of	NULL
T-cell	NULL
G1	NULL
progression	NULL
and	NULL
c-myb	NULL
expression	NULL
.	NULL

Science	NULL
,	NULL
233	NULL
,	NULL
203-206	NULL
.	NULL

Taylor	NULL
,	NULL
D.	NULL
,	NULL
Badiani	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Weston	NULL
,	NULL
K	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
A	NULL
dominant	NULL
interfering	NULL
myb	NULL
mutant	NULL
causes	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

,	NULL
10	NULL
,	NULL
2732-2744	NULL
.	NULL

Teixido	NULL
,	NULL
J.	NULL
,	NULL
Hemler	NULL
,	NULL
M.E	NULL
.	NULL

,	NULL
Greenberger	NULL
,	NULL
J.S	NULL
.	NULL

and	NULL
Anklesaria	NULL
,	NULL
P	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Role	NULL
of	NULL
beta	NULL
1	NULL
and	NULL
beta	NULL
2	NULL
integrins	NULL
in	NULL
the	NULL
adhesion	NULL
of	NULL
human	NULL
CD34hi	NULL
stem	NULL
cells	NULL
to	NULL
bone	NULL
marrow	NULL
stroma	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
90	NULL
,	NULL
358-367	NULL
.	NULL

3933	NULL
A.A.Postigo	NULL
et	NULL
al	NULL
.	NULL

Torelli	NULL
,	NULL
G.	NULL
,	NULL
Selleri	NULL
,	NULL
L.	NULL
,	NULL
Donelli	NULL
,	NULL
A.	NULL
,	NULL
Ferrari	NULL
,	NULL
S.	NULL
,	NULL
Emilila	NULL
,	NULL
G.	NULL
,	NULL
Venturelli	NULL
,	NULL
D.	NULL
,	NULL
Moretti	NULL
,	NULL
L.	NULL
and	NULL
Torelli	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Activation	NULL
of	NULL
c-myb	NULL
expression	NULL
by	NULL
phytohemagglutinin	NULL
stimulation	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
5	NULL
,	NULL
2874-2877	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
Hahn	NULL
,	NULL
S.L	NULL
.	NULL

and	NULL
Giovane	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eur	NULL
J	NULL
.	NULL

Biochem	NULL
.	NULL

,	NULL
211	NULL
,	NULL
7-18	NULL
.	NULL

Weintraub	NULL
,	NULL
S.J	NULL
.	NULL

,	NULL
Chow	NULL
,	NULL
K.N	NULL
.	NULL

,	NULL
Luo	NULL
,	NULL
R.X	NULL
.	NULL

,	NULL
Zhang	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
He	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Dean	NULL
,	NULL
D.C	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mechanism	NULL
of	NULL
active	NULL
transcriptional	NULL
repression	NULL
by	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

Nature	NULL
,	NULL
375	NULL
,	NULL
812-815	NULL
.	NULL

Yasuda	NULL
,	NULL
H.	NULL
,	NULL
Mizuno	NULL
,	NULL
A.	NULL
,	NULL
Tamaoki	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Torinaga	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
ATBF1	NULL
,	NULL
a	NULL
multiple-homeodomain	NULL
zinc	NULL
finger	NULL
protein	NULL
,	NULL
selectively	NULL
down-regulates	NULL
AT-rich	NULL
elements	NULL
of	NULL
the	NULL
human	NULL
alpha-fetoprotein	NULL
gene	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
14	NULL
,	NULL
1395-1401	NULL
.	NULL

Yednock	NULL
,	NULL
T.A	NULL
.	NULL

,	NULL
Cannon	NULL
,	NULL
C.	NULL
,	NULL
Fritz	NULL
,	NULL
L.C	NULL
.	NULL

,	NULL
Sanchez-Madrid	NULL
,	NULL
F.	NULL
,	NULL
Steinman	NULL
,	NULL
L	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Prevention	NULL
of	NULL
experimental	NULL
autoimmune	NULL
encephalomyelitis	NULL
by	NULL
antibodies	NULL
against	NULL
alpha	NULL
4	NULL
beta	NULL
1	NULL
integrin	NULL
.	NULL

Nature	NULL
,	NULL
356	NULL
,	NULL
63-66	NULL
.	NULL

Received	NULL
on	NULL
February	NULL
5	NULL
,	NULL
1997	NULL
;	NULL
revised	NULL
on	NULL
March	NULL
26	NULL
,	NULL
1997	NULL
3934	NULL

